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ABSTRACT

TRANSPORT AND METABOLISM OF GLYCEROPHOSPHODIESTERS BY
CANDIDA ALBICANS

By
Andrew C. Bishop
May 2013

Dissertation supervised by Jana Patton-Vogt, Ph.D.
Glycerophosphodiesters are products of phospholipase B-mediated hydrolysis of
phospholipids. Their transport and metabolism is elaborated in the fungal pathogen,
Candida albicans, as compared to the non-pathogenic Saccharomyces cerevisiae. C.
albicans contains four ORFs (CaGIT1-4) predicted to encode transporters for
glycerophosphodiesters, compared to one (ScGIT1) in S. cerevisiae. Here I have
identified the gene products responsible for glycerophosphoinositol (GroPIns) and
glycerophosphocholine (GroPCho) transport. C. albicans strain lacking ORF 19.34,
which codes for CaGit1, is unable to transport intact GroPIns. Transport activity can be
rescued by reintegration of one copy of CaGIT1 back into the genome. Similarly, a strain
lacking CaGIT3 (ORF 19.1979) and CaGIT4 (ORF 19.1980) is unable to transport intact
GroPCho into the cell. Reintegrating one copy of either CaGIT3 or CaGIT4 can rescue
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GroPCho transport activity. Initial transport assays and kinetic analyses indicate that
CaGit3 is responsible for the majority of GroPCho transport activity. In addition, I
present evidence that CaGDE1 (ORF 19.3936) codes for an enzyme with
glycerophosphodiesterase activity against GroPCho. Homozygous deletion of CaGDE1
results in a buildup of internal GroPCho, which is restored to wild type accumulation by
reintegration of one copy of CaGDE1 into the genome. The transcriptional regulator,
CaPho4, was shown to positively regulate the expression of CaGIT1, CaGIT3, CaGIT4,
and CaGDE1. Finally, glycerophosphodiester transport and metabolism was active under
physiological relevant conditions that C. albicans may experience in the human host.
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Chapter 1
Introduction
1.1 The Candida genus and Candida albicans
The Candida genus contains over 200 different species and a small percentage of
these species are known to pose a risk to humans. The non-human pathogen related
species have been isolated from various environments and include: C. materiae, C.
amazonensis, C. cellulosicola, C. saraburiensis, C. prachuapensis and C. queiroziae
from decaying plant matter (1-5); C. northwykensis, C. easanensis, C. pattaniensis, C.
nakhonratchasimensis and C. ficus from insect guts or excrements (6-8); and C.
thasaenesis and C. digboiensis from hazardous wastes (9,10). Although these species
pose no known threat to humans, they display the versatility of the Candida genus by
their ability to colonize and survive in a variety of environments.
C. albicans is a human pathogen that resides in the gastrointestinal tract, oral
cavity, and vaginal cavity of healthy individuals where it serves as a member of the
natural microbial flora (11-13). Although other Candida species (C. glabrata,
C. parapsilosis, C. tropicalis, and C. krusei) cause infections in a human host,
C. albicans-related infections are believed to be the most common and have to the most
impact on human health (14). Of all acquired blood stream infections, including those
arising from bacteria, Candida infections are the 4th most common, costing roughly
$40,000 extra per hospital patient that acquires candidemia (15). C. albicans is more
likely to cause a major infection under conditions where the host loses its ability to
combat the pathogen. Therefore, infection is most common in ICU patients and
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individuals with compromised immune systems due to diseases like HIV, those receiving
cancer treatments, or those on an immunosuppressant therapy (14,15). Due in part to its
medical relevance, much research has focused on understanding C. albicans biology and
pathogenicity.

1.2 Morphological Forms
C. albicans can exist in three distinct morphological forms (16): yeast, hyphal and
pseudohyphal. These forms differentiate C. albicans from its distant relative,
Saccharomyces cerevisiae (16,17), which mainly exists in the yeast form, but can be
induced to the pseudohyphal form. The two species are believed to have diverged from
each other more than 800 million years ago (18). C. albicans cells in the yeast
morphology can be described as growing similarly to that of S. cerevisiae, where a
daughter cell buds from a mother cell, producing two separate cells. In hyphal growth,
the cells do not bud, but produce long filaments that protrude from the mother cell with
no constrictions (16). The intermediate psuedohyphal form has both yeast and hyphal
characteristics, but is never consistently in either form. It produces larger buds than the
yeast form but with constricted filaments that do not completely detach from each other
(16). C. albicans can readily switch between the three morphological forms depending on
environmental conditions (16) and this ability to switching is essential for the organism’s
virulence (17).
C. albicans has been studied in two well defined types of growth, planktonic and
biofilm growth. Planktonic consists of free floating cells, grown in well aerated cultures.
Biofilm growth involves adherence to a surface, creating a complex community of cells
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and extracellular matrices (19). All three morphological forms of C. albicans are present
and contribute to the formation of biofilms (19). To initiate biofilm formation, free
floating yeast cells adhere to host surface proteins or to implanted devices (i.e. catheters,
pace makers, prosthetics, etc.) (19,20). The cells then go through morphological changes,
initiating hyphal formations and the production of an extracellular matrix as the biofilm
grows and matures (20). Once the biofilm has fully matured, it will begin to disseminate
yeast form cells that break away from the biofilm and travel to other locations in the host
(19,20). The progressive nature of biofilm formation by C. albicans relies on certain
adaptations that are driven by virulence factors. These factors are gene products that aid
the organism's ability to survive in environments uninhabitable by non-pathogenic
organisms.

1.3 Properties that Influence Virulence of C. albicans
Many C. albicans virulence factors are involved in the processes of phenotypic
switching, morphological dimorphism, cell adhesion and the production of hydrolytic
enzymes (17). One well studied example of phenotypic switching is a system involving
the transition of cell growth from white round colonies consisting of normal yeast cells to
opaque colonies that consist of irregular and elongated cells (21,22). This white to
opaque transition can influence the ability of C. albicans to invade host tissue (22-24).
Various environmental cues can influence phenotypic switching including oxidative
stress, starvation, or growth in the presence of serum or N-Acetylglucosamine (23).
A morphological change is the ability to readily switch between yeast, hyphal and
pseudohyphal growth (16,17). These changes in morphology can occur in response to
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alterations in pH, temperature, CO2 concentrations or other environmental cues (17).
Morphological dimorphism can impact virulence in two different ways, i) through the
formation of pseudohyphae and hyphae, which are required for tissue invasion, and ii)
through the ability to disseminate yeast cells that can easily travel through the host's
blood stream and within infected tissues to create new sites of infection (17).
Adherence, the ability of cells to bind to a surface, is the first step in the formation
of biofilms (20) and is also required for tissue invasion (17). Once cells adhere to a
surface they must acquire nutrients that may not be readily available from their current
environment. Hydrolytic enzymes, which are known virulence factors, aid in this process
by releasing nutrients that can be used by the cell (17). These enzymes include proteases,
lipases, and phospholipases, which serve to attack proteins, lipids, and phospholipids
(17). Many of these enzymes are active during infection (25), contributing to the
pathogenicity of C. albicans.

1.4 Phospholipids and Phospholipases
Phospholipases are universal, having been found in bacteria, plants, fungi, and
mammals (26-28). Phospholipases catabolize phospholipids through the hydrolysis of
specific bonds of phospholipids. Phospholipids are composed of four primary
components: a polar head group, a phosphate group, a glycerol backbone, and two fatty
acyl esters. In Figure 1-1, a schematic of a phospholipid is represented with the possible
polar head groups. Various combinations of different phospholipids contributes to the
heterogeneous character of cellular membranes and the functionality of membrane

4

Figure 1-1. Potential cellular membrane phospholipids. A generic structure of a
phospholipid containing a phosphate group and two fatty acyl esters attached to a
glycerol backbone. The X on the phosphate group can represent any of the potential polar
head groups pictured to create the listed phospholipids. Modified with permission from
Tao Sun.
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Figure 1-2. Sites of phospholipid hydrolysis by four distinct types of phospholipases
Phospholipase (PL) A1, A2, B, C, and D hydrolyze different location on a phospholipid
producing various phospholipid metabolites. R1 and R2 represent any length fatty acyl
chain. R3 represents any polar head group (Choline, Inositol, Ethanolamine, Serine,
Glycerol).

Figure 1-3. Phospholipase B mediated hydrolysis of a phospholipid into a
glycerophosphodiester and free fatty acids. R1 and R2 represent any length for the fatty
acid tails. R3 represents any potential polar head group.
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proteins. The bond that the phospholipase attacks determines its categorization as either
A, B, C, or D (29) (FIG1-2). Phospholipase A (PLA) enzymes are made up of two
groups, PLA1, which attacks the sn-1 acyl esters, and PLA2, which attacks the sn-2 acyl
esters on the glycerol backbone of phospholipids (29). If only one of these enzymes acts
on a phospholipid, a lysophospholipid containing one acyl ester is produced. If both
PLA1 and PLA2 act on a phospholipid, a glycerophosphodiester and free fatty acids are
produced. Phospholipase B (PLB) enzymes attack both the sn-1 and sn-2 positions on
the glycerol backbone producing glycerophosphodiesters and free fatty acids (26,29)
(FIG1-3). The reaction in Figure 1-3 is a common occurrence in S. cerevisiae, where it
can serve as the first step in the recycling of phospholipid metabolites of cellular
membranes (30). From the phospholipids listed in Figure 1-1, this reaction can produce
the following: glycerophosphoglycerol (GroPG), glycerol-3-phosphate (GroP),
glycerophosphoethanolamine (GroPE), glycerophosphoserine (GroPS) and the two
glycerophospdiesters relevant to this study, glycerophosphoinositiol (GroPIns) and
glycerophosphocholine (GroPCho). Some PLBs also have lysophopholipase transacylase
activity to produce phospholipids from lysophospholipids (31). Phospholipase C (PLC)
enzymes attack phosphodiester bonds located between the phosphate group and the
glycerol backbone producing 1,2-diacylglycerol and a phosphate monoesters, the identity
of which depends on the particular glycerophospholipids being attacked (26,32).
Phospholipase D (PLD) enzymes attack the ester bond between the phosphate group and
the polar head group of the glycerophospholipid, producing phosphatidic acid and the
respective alcohol (26,29).
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All four types of phospholipase activities are present in C. albicans, but only
select PLBs and the sole PLD have been reported to be tied to virulence (29,31-34). The
C. albicans genome contains multiple ORFs (CaPLB1-5) that are predicted to encode
PLB enzymes based on having a catalytic domain that is common for phospholipases of
the B type as indicated on the Candida Genome Database (CGD,
www.candidagenome.org) using InterPro (IPR002642) (35). Two of these ORFs,
CaPLB1 (ORF19.689) and CaPLB5 (ORF19.5102) have been implicated in the virulence
of C. albicans (31,34). Disruption of CaPLB1 resulted in attenuated virulence in an
intravenous mouse model, and upon reintegration of one copy of CaPLB1, virulence was
restored (34). Additionally, CaPLB1 has been shown to be expressed under elevated
temperature, pH and in the presence of both serum and phospholipids (36), conditions C.
albicans may experience in a human host. Disruption of CaPLB5 also attenuated
virulence and reduced organ burden of the kidneys, liver, and brain in a mouse model
(31). Reconstitution of one copy of CaPLB5 restored virulence (31). CaPLB2
(ORF19.690) is expressed during infection, but its importance during the infection
process is unknown (25,37). CaPLB3 (ORF19.6594) is predicted to be a GPI anchored
protein (38,39) and has been detected extracellularly (40). CaPLB3 expression is induced
by treatment of cells with the antifungal drug fluconazole (40), but the gene has not been
linked to virulence. In the current assembly of ORFs on CGD, there have been some
changes to the putative CaPLB4. Originally ORF 19.1442 and ORF19.1443 were both
recognized as putative PLB ORFs, but in the new assembly the two ORFs have been
merged into CaPLB4.5 (ORF 19.1442). A role of CaPLB4.5 has yet to be determined, but
it has been described as a putative GPI anchored protein (39). Several laboratories have
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studied the PLBs of C. albicans, and in many cases, a link to virulence has been found. In
contrast, these studies have not addressed the fate of glycerophosphodiesters, the
products of PLB activity (FIG1-3).

1.5 Glycerophosphodiester Transport and Catabolism
Our current understanding of glycerophosphodiester transport and catabolism is
based on work from bacteria, plants, mammalian cells and most importantly, S.
cerevisiae. With S. cerevisiae and C. albicans diverged from each other over 800 million
years ago (18), major difference exist between the two organisms. However, using the
well-characterized S. cerevisiae as a foundation for studies in C. albicans is common.
Although there are limitations to this process, it provides a starting point for the
characterization of genes in C. albicans.
A schematic representation of phospholipid deacylation and
glycerophosphodiester recycling in S. cerevisiae is detailed in Figure 1-4. Phospholipids
(Phosphatidylinositol (PI) and Phosphatidylcholine (PC)) can be hydrolyzed at the cell
membrane by PLBs (reaction in FIG 1-3) to release free fatty acids and
glycerophosphodiesters (GroPIns and GroPCho). ScPlb1 has been shown to be specific
for PC, while ScPlb3 is specific for PI (30). GroPIns and GroPCho are released into the
periplasmic space, and subsequently transported into the cell by the permease ScGit1.
ScGit1 is the only glycerophosphodiester permease in S. cerevisiae, and has a higher
affinity for GroPIns than GroPCho (30). Sources of GroPIns and GroPCho are not limited
to the plasma membrane phospholipids, but can also be obtained from the environment.
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Figure 1-4. Phospholipid deacylation pathway in S. cerevisiae. Details are provided in
the text. In this schematic, phospholipids, phosphatidylinositol (PI) and
phosphatidylcholine (PC) are represented in blue. Proteins: Plb1-3, Git1, and Gde1 are
represented in green. Phospholipid metabolites: GroPIns, GroPCho, free fatty acids, GroP
and choline are represented in orange.
.
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Once GroPCho and GroPIns are transported into the cell, the protein Gde1, the only
characterized glycerophosphodiesterase in S. cerevisiae , hydrolyzes GroPCho into GroP
and free choline (30). Currently, the enzyme responsible for the hydrolysis of GroPIns is
unknown, but like choline, inositol can be reutilized for lipid biosynthesis to create new
phospholipids (30).
In mammalian cells, a functional homolog to ScGit1 exists, Glut2, which is
responsible for transporting GroPIns (41). Expression of Glut2 was found to be tissue
specific, localized to the liver, kidney and small intestine (42). In contrast to the
eukaryotic transporters, E. coli deploys a multi-protein complex consisting of 5 proteins
(UgpB, A, E, C, and Q) that work together to transport glycerophosphodiesters into the
cell (43-45). Interestingly, it is believed that the glycerophosphodiesters are hydrolyzed
by a glycerophosphodiesterase (UgpQ) as they are being transported into the cell (44). In
the eukaryotic systems, glycerophsphodiesterase activity is independent of transport.
In general, a glycerophosphodiesterase hydrolyzes glycerophosphodiesters into
GroP and their respective alcohols (30,46). Proteins thought to contain
glycerophosphodiesterase domains can be identified using InterPro (IPR004129) (35),
where they are categorized by a conserved catalytic domain. Glycerophosphodiesterase
activity has been tied to a number different biological functions including the production
of skeletal muscle (47), osmotic regulation in the kidneys (48) and phosphate utilization
in E. coli (43), Arabidopsis thaliana (49), White Lupin (50) and S. cerevisiae (30).
Proteins with glycerophosphodiesterase motifs are assumed to hydrolyze only
glycerophosphodiesters, but recently a mammalian glycerophosphodiesterase, (GDE2),
has been implicated in neurogenesis through the cleavage of GPI anchors (51). Therefore
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the enzymatic substrates may go beyond the hydrolysis of glycerophosphodiester bonds,
at least for mammals.
In the preceding section (1.5), I have provided a general overview of
glycerophosphodiester transport and catabolism using literature that predates the work
performed for my dissertation project. More detailed information can be found in the
introduction to each of my publications that constitute Chapters 2 and 3.

1.6 Objective
The overall goal of this work was to characterize the transport and metabolism of
glycerophosphodiesters by the pathogen C. albicans. Several compelling facts led to my
interest in pursuing this project. Firstly, C. albicans has four uncharacterized ORFs
(CaGIT1-4) predicted to be involved in glycerophosphodiester transport, compared to
one in the non-pathogenic S. cerevisiae. Secondly, GroPCho and GroPIns are found in
tissues and fluids throughout the human body, where they can potentially be used by C.
albicans as nutrient sources during infection. Lastly, PLBs, which produce
glycerophosphodiesters, have been linked to virulence of C. albicans. The specific
objectives of my work were i) to examine glycerophosphodiester transport and
metabolism in a variety of conditions that C. albicans may encounter in the human host,
ii) to identify and characterize gene product(s) responsible for the facilitating the
transport of intact GroPCho and GroPIns into the cell and iii) to identify and characterize
a gene product responsible for the internal catabolism of GroPCho.
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Chapter 2
Robust Utilization of Phospholipase-Generated Metabolites,
Glycerophosphodiesters by Candida albicans: Role of the
CaGit1 Permease
Andrew C. Bishop, Tao Sun, Mitchell E. Johnson, Vincent M. Bruno, and Jana
Patton-Vogt
Reprinted from Eukaryotic Cell, Vol.10, No. 12, Andrew C. Bishop, Tao Sun, Mitchell E.
Johnson, Vincent M. Bruno and Jana Patton-Vogt, Robust Utilization of PhospholipaseGenerated Metabolites, Glycerophosphodiesters by Candida albicans: Role of the CaGit1
Permease pages1618-1627., Copyright (2011) with permission from American Society of
Microbiology
Chapter 2 Attributions
I did all of the work in this chapter expect those noted here:
Claudia Almaguer, a technician in Dr. Jana Patton-Vogt’s laboratory, constructed
strains git1-/- +pDDB78 (JPV526) and git1-/- +pDDB78GIT1 (JPV512).
Tao Sun, a graduate student in Dr. Mitch Johnson’s laboratory, performed the LC-MS
analysis of extracellular levels of glycerophosphoinositol.
2.1 Introduction
Glycerophosphodiesters result from the complete deacylation of
glycerophospholipids via phospholipase-mediated hydrolysis. Most fungal cells,
including C. albicans and S. cerevisiae, contain multiple phospholipase B (PLB)encoding genes (29) that act on both fatty acyl ester groups to produce
glycerophosphodiesters, such as glycerophosphocholine (GroPCho) and
glycerophosphoinositol (GroPIns) (30). The potential role of C. albicans PLBs as
virulence factors has been explored by others (34,36,52-54). For example, C. albicans
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strains exhibiting elevated PLB activity have been shown to be associated with increased
virulence in mouse models of disseminated candidiasis (55). Disruption of PLB1 was
subsequently shown to result in attenuated virulence in a mouse model (53), and
reintroduction of a functional PLB1 into this mutant to restore virulence to levels
observed for the parental strain (34). Also, inactivation of another PLB gene, PLB5, has
been shown to result in attenuated virulence (31). Notably, the fate and potential function
of the products of PLB turnover, the glycerophosphodiesters, have not been addressed.
Although glycerophosphodiesters are produced via C. albicans PLB activity, the
organism, being an opportunistic commensal, is also likely exposed to sources of
glycerophosphodiesters that are present in the host as a result of host phospholipase
activity. Indeed, the literature indicates that glycerophosphodiesters, especially GroPIns
and GroPCho, are present in serum, as well as other mammalian fluids and tissues. For
example, GroPCho is an abundant organic osmolyte found in the renal medulla of the
kidney (48,56) and both GroPIns and GroPCho are found in other parts of the urinary
tract, including renal proximal tubules (57). GroPCho has also been found in organs of
the gastrointestinal tract, including the small and large intestines (58-60). Serum,
cerebral spinal fluid, and brain tissue contain GroPCho, in addition to
lysophosphatidylcholine and phosphatidylcholine that can be converted to GroPCho via
phospholipases B (61-63). GroPIns has also been noted in other cells and tissues,
including brain, kidney, and others (64).
In S. cerevisiae, extracellular GroPIns and, with less affinity, GroPCho, are
transported into the cell via the ScGit1 transporter. Once inside the cell, they are
metabolized and used as sources of nutrients such as phosphate, inositol, and choline (65-
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67). C. albicans contains four open reading frames (ORFs) (CaGIT1-4) predicted to
encode transporters with a high degree of similarity to S. cerevisiae GIT1 (ScGIT1)
product (68). ScGit1 and CaGit1-4 are classified as members of the major facilitator
superfamily (MFS) (69). The MFS is present in all kingdoms of life. Most MFS proteins
are between 400-600 amino acids in length and contain either 12 or 14 membranespanning segments. MFS proteins faclitate symport, antiport, or uniport of various
substrates. Those substrates include nutrients, drugs, nucleotides, nucleosides, and other
metabolites (70). Using the Transport Commission (TC) system (71), 95 potential MFS
proteins clustering into 17 families have been predicted for C. albicans (69), but only a
handful have been characterized. Like ScGit1, CaGit1-4 are predicted to belong to the
phosphate: H+ symporter (PHS) family (TC no. 2.A.1.9) of the MSF (69). In total, the C.
albicans genome is predicted to have 5 PHS family members: CaGit1-4, and the homolog
of the S. cerevisiae high affinity phosphate transporter, Pho84. No member of this family
has been characterized in C. albicans.
Here, we investigate the ability of C. albicans to transport GroPIns and GroPCho
into the cell and to utilize those compounds as sources of phosphate. In addition, we
identify CaGIT1 (orf19.34) as a GroPIns permease.

2.2 Materials and Methods
2.2.1 Strains and media: Strains were grown aerobically at either 30°C or 37°C with
shaking. Turbidity was monitored by measurement of optical density at 600 nm (OD600)
on a Biomate 3 Thermo Spectronic spectrophotometer. Synthetic complete (yeast
nitrogen base [YNB]) medium was prepared as described previously (72). High Pi and
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low Pi media were made by replacing the KH2PO4 (1 gm/liter) in synthetic complete
medium with KCl (1 gm/liter) and adding KH2PO4 to 10 mM (high Pi) or 0.2 mM (low
Pi). All media for C. albicans was supplemented with 80 µg/ml of uridine. For some
experiments, media lacking KH2PO4 (no-Pi medium) contained GroPIns (Sigma
#G1891), GroPCho (Sigma #G5291) or glycerol-3-phosphate (GroP) (Sigma #G7886) at
the indicated concentrations. Where indicated, YNB was buffered to pH 7.5 using 150
mM HEPES. Strains were maintained on yeast extract-peptone-dextrose (YEPD) media
consisting of 20 g glucose, 10 g yeast extract, and 20 g bacto peptone per liter. The
genotypes of C. albicans strains are indicated in Table 2-1. The S. cerevisiae strain,
BY4741, is MATa his3∆1 leu2∆0 met15∆0 ura3∆0.
Table 2-1 Strain Table Chapter 2

2.2.2 Construction of homozygous insertion mutant. A clone of the GIT1 gene
containing a Tn7-UAU transposon insertion produced via UAU1 methodology (73,74)
was obtained from Aaron Mitchell, Carnegie Mellon University. Plasmid CAGFN83
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(clone ID#29331) bears the GIT1 gene containing the UAU1 insertion at bp 536.
CAGFN83 was digested with NotI to release the Tn7-UAU1 mutagenized GIT1 gene and
transformed into strain BWP17 (ura3::imm434/ura3::imm434 his1::hisG/his1::his
arg4::hisG/arg4::hisG; (75). Several Arg+ transformants were isolated and subjected to
Arg+ Ura+ selection as described (73,75). Genomic DNA was extracted from Arg+ Ura+
transformants and PCR was performed using forward primers Arg4det (5’GGAATTGATCAATTATCTTTTGAAC-3’) (76), and GITF2 (5’TTCGGACAAGTGATTATTGGATTAACCGCT-3’), and reverse primer GITR3 (5’TATAACTGACAAGCAGAAGAAAGGGGTTTA-3’). Heterozygous insertion mutants
displayed two bands upon PCR: a 1.3 Kb fragment corresponding to GIT1 allele
amplified with primers GITF2 and GITR3, and a 2.7 Kb fragment corresponding to the
presence of the git1::Tn7-UAU1 allele amplified with primers Arg4det and GITR3.
Homozygous insertion mutants, git1::UAU1/git1::URA3 (JPV484), displayed only the
2.7 kb band. The git1::UAU1/git1::URA3 mutant is also referred to here as git1-/-.

2.2.3 Construction of plasmid pDDB78GIT1. GIT1 was amplified from genomic DNA
using a forward primer incorporating a NotI restriction site (bold) located 900 bp
upstream of the start site (5’AATGTTAAATGCGGCCGCTGTACACGGCTTTATCGCACGGGATATGAA-3’)
and a reverse primer incorporating an EcoRI restriction site (bold) located 540 bp
downstream of the stop site (5’AATGTTAAAGGGGAATTCGAAATTTGGTTATGTAGGGTTCAGTTAAAA-3’).
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The resulting PCR product and plasmid pDDB78 (77) were digested with NotI and
EcoRI and ligated together to obtain plasmid pDDB78GIT1.

2.2.4 Insertional complementation of git1::UAU1/git1::URA3. Plasmid pDDB78GIT1
was linearized by cutting within the HIS1 gene with NruI and the resulting product was
transformed into git1::UAU1/git1::URA3 (JPV484) to produce JPV512, referred to here
as git1::UAU1/git1::URA3 + pDDB78GIT1 (77). Several His+ transformants were
selected and tested for complementation of the mutant phenotype. Empty plasmid
pDDB78 was also linearized and transformed into git1::UAU1/git1::URA3 (JPV484) to
produce JPV526, referred to here as git1::UAU1/git1::URA3 + pDDB78.

2.2.5 Screening of the transcriptional regulator deletion set: The deletion library (78)
was purchased from the Fungal Genetics Stock Center (FGSC). The deletion strains were
constructed in strain SN152 (arg4∆/arg4∆, leu2∆/leu2∆, his1∆/his1∆, URA3∆/ura3∆,
IRO1∆/iro1∆). The auxotrophic markers HIS1 and LEU2 were used to delete the genes,
as described (78). A wild type control strain in which HIS1 and LEU2 were reintroduced
into the parent strain (WT-TF) was included in the set. The deletions strains were
screened by growing in liquid YNB medium containing either 200 M GroPIns or 200
M KH2PO4 as the source of phosphate. Growth after 48 hours at 37C was monitored.

2.2.6 [3H]inositol-GroPIns and [3H]choline-GroPCho uptake assays: Label uptake
assays (also referred to as transport assays) were performed essentially as described
previously (65). For the standard assay, aliquots of the cultures were harvested and
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washed with sterile water. Each cell pellet was suspended in 100 mM sodium citrate
buffer, pH 5.0 to OD600= 5. Following 10 min incubation at 30oC with agitation, the
reaction was started by the addition of 50 l of 25 M [3H]GroPIns or 50 l of 1 mM
[3H]GroPCho to 200 l of the cell suspension to produce final concentrations of 5 M
[3H]GroPIns and 200 M [3H]GroPCho. Following 10 min (for GroPIns transport) or 2
min (for GroPCho transport) incubation at 30C, the reaction was stopped by the addition
of 10 ml ice-cold H2O. The samples were filtered through glass fiber (GF/C) filters, and
the filters washed with ice-cold H2O. Radioactivity on the filter was determined by liquid
scintillation counting. Data are presented as pmol/min/optical density unit at OD 600 nm
(ODU). For S. cerevisiae, transport assays were performed as described above for the
standard C. albicans assays, with the exception that for both [ 3H]GroPIns and
[3H]GroPCho a final concentration of 5 M was used in 10 min assays. Tritium labeled
GroPIns ([3H]inositol-GroPIns) and tritium labeled GroPCho ([ 3H]choline-GroPCho)
were produced through the deacylation of phosphatidyl-myo-[2-3H]inositol (American
Radiolabeled Chemicals) and phosphatidyl-methyl-[3H]choline (American Radiolabeled
Chemicals) as described previously (79).
For the GroPIns transport competition assays, conditions were identical to those
described above except that 25 mM HEPES buffer (pH 5) was used instead of citrate
buffer and the transport assay mixtures included 1 mM GroPIns, 1 mM inositol, 1 mM
KH2PO4, or 1 mM GroP, as indicated. The pH of the assays did not change during the
course of the experiment. For the protonophore experiment, 100 mM Carbonyl cyanide 3chlorophenylhydrazone (CCCP) (Alfa Aesar #L06932) stocks in ethanol were added to
25 mM HEPES buffer for a final concentration of 50 M. For the experiments involving
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alterations in transport assay pH, 25 mM HEPES buffer was adjusted to pH 6.5, pH 7.5 or
pH 8.5, as indicated.
For the determination of GroPIns transport kinetics (FIG 2-5), assays were
performed in 100 mM Citrate buffer, pH 5. Transport was started with the addition of 50
l of [3H]GroPIns ranging in concentrations from 5 M to 500 M of GroPIns, as
indicated. Transport activity was linear with time at each substrate concentration used.
Assays were stopped after 5 min. Saturation kinetics data for GroPIns was analyzed using
the Levenberg-Marquardt algorithm for nonlinear regression in Graphpad Prism (version
4.0) to determine the apparent Km and Vmax. Values were determined by least squares
fitting of the data to the Michaelis-Menten equation V=Vmax[S](Km+[S])-1, where S
represents GroPIns. The saturation kinetics data was manipulated to show linearization
by a Hanes plot transformation (80).

2.2.7 LC-MS analysis of GroPIns uptake: A 250 μl portion of each medium sample
was diluted 5-fold in methanol-water (90:10) and centrifuged at 10,000 X g for 5 min.
The supernatants were transferred into high-pressure liquid chromatography (HPLC)
vials, dried down by nitrogen gas, resuspended in 250 μl of 75:25 acetonitrile-methanol,
and placed in the autosampler of the LC system. Samples were analyzed using an Agilent
6460 triple-quadrupole mass spectrometer (MS) coupled to an Agilent 1200 LC system.
The scan mode was set to multiple-reaction monitoring (MRM) targeted for
fragmentation of GroPIns (333153) in negative-ionization mode. The capillary voltage
was set to -3.5 kV, the fragmentor voltage to 50 V, and the collision energy to 20 eV,
with a dwell time of 200 ms. The drying gas flow rate was set to 8 liters/min, and the
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nebulizer pressure was 50 lb/in2. Hydrophilic interaction liquid chromatography (HILIC)
was performed with a 5 μm XBridge column (150 by 4.60 mm, Waters, Milford, MA).
The mobile phase was 50:50 acetonitrile-water containing 10 mM NH4 Acetate
(NH4OAC), with a resulting pH of 7.19. The chromatography was performed using
isocratic elution at a flow rate of 0.5 ml/min. An injection volume of 10 μl was used and
each sample was run in triplicate. Data were analyzed by MassHunter workstation
software (Agilent). The peak area of GroPIns was compared with the external calibration
curve to calculate its relative concentration in the medium.

2.2.8 Analysis of internal [3H]GroPIns metabolites: Following a standard [3H]GroPIns
transport assay, internal counts were isolated via trichloroacetric acid (TCA) extraction
(81) and separated by ion-exchange chromatography essentially as described previously
(72). Briefly, at the conclusion of a 5-min [3H]GroPIns transport assay, 750 l of sterile
water was added to the 250 l cell suspension and the cells were pelleted. The cells were
washed with 500 l of sterile water and repelleted. The pelleted cells was then suspended
in 100 l of a 5% TCA solution and incubated on ice for 10 min. After the incubation, the
cells were pelleted, the supernatant, containing the intracellular water-soluble
metabolites, was removed to a fresh tube. An equal volume of 1M Tris (pH 8) was added
to the supernatant to neutralize it. Neutralized samples were diluted and applied to 1 ml
of Dowex 1X8-400 anion-exchange columns. Potential inositol containing metabolites
(inositol, GroPIns, inositol-phosphate) were eluted from the column as described
previously (72). Appropriate tritium-labeled standards were used to validate this
procedure. Radioactivity was determined using scintillation counting.
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2.2.9 RNA Extraction and qRT-PCR gene expression analysis. Cultures were grown
in either low Pi or high Pi medium supplemented with 80μg/ml uridine to an OD600
between 0.8 and 1.2. RNA was extracted using a hot phenol-chloroform extraction (82).
RNA was DNase treated using the TURBO DNA-free Kit (Applied Biosystems). A 5 g
sample of RNA was treated with 2 units of DNase and incubated at 37C for 30 min.
Samples were stored at -80oC until analysis. Primer 3 software
(http://frodo.wi.mit.edu/primer3/) was used to design primers for CaGIT1 FOR: 5'CGCATCTTTGTCAACTCAAG-3' and REV: 5'-TAGCAGCTTCACTTGCTGTC-3'.
Primer sequences for the endogenous control (CaTDH3) were: FOR: 5'TGCTAAAGCCGTTGGTAAGG and REV: 5'-AAATCGGTGGAGACAACAGC-3'
(83). Real time RT-PCR was performed using Power SYBR Green RNA-to-CT 1-Step
Kit (Applied Biosystems). Each reaction consisted of 0.2 l of a 125X RT Enzyme mix,
12.5 l of a 2X RT-PCR, 500 nM of primers, and 1.5 l DNase treated RNA in a total
volume of 25 l. Experimental samples were analyzed in triplicate on an Applied
Biosystems StepOnePlus instrument. Reverse transcription was carried out at 48C for 30
min, followed by 95C for 10 min for RT inactivation and polymerase activation,
followed by 40 cycles for amplification at 95C for 15 s, 50C for 30 s, and 72C for 40
s, followed by the melt curve to check for primer specificity. A no-template and minus
reverse transcriptase control reactions were performed to confirm lack of contamination
in the RNA samples and/or the reagents. CaGIT1 expression was analyzed using the

CT Method (84) and normalized to the endogenous control CaTDH3 expression. Wild
type strain grown in low-Pi was normalized to 1 and used as a comparison for fold
change.
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2.3 Results
2.3.1 Potential ScGIT1 homologs found in the C. albicans genome. Four ORFs with
high similarity to ScGIT1, the gene that encodes the S. cerevisiae GroPIns and GroPCho
transporter, have been identified in the C. albicans genome (68,69). CaGIT1 corresponds
to orf19.34. Currently, the Candida genome Database (CGD,
http://www.candidagenome.org) has CaGIT1 as the primary designation for orf19.34, but
has noted a nomenclature conflict in that both orf19.34 and orf19.1979 have previously
been called CaGIT1. A WU-BLAST2 search reveals that CaGit1 displays 53% identity
and 69% similarity to ScGit1 over 504 amino acids (97% of the protein). CaGIT1 resides
on chromosome 2, while CaGIT2-4 (orfs19.1978-19.1980) lie in a tandem repeat on the
left arm of chromosome 5 and are highly similar to each other. CaGit2 (orf19.1978)
displays 75% identity and 86% similarity with CaGit3 (orf19.1979) and 69% identity and
81% similarity to CaGit4 (orf19.1980) in regions covering at least 95% of the predicted
proteins.

2.3.2 Role of CaGit1 in the utilization of GroPIns and GroPCho as phosphate
sources. As shown in Fig. 2-1, a wild type C. albicans strain (DAY185) is able to utilize
both GroPIns (Fig. 2-1A) and GroPCho (Fig. 2-1B) as sources of phosphate. As
expected, the wild type strain grew when KH2PO4 was supplied (Fig. 2-1C), but did not
grow when no phosphate source was supplied (Fig. 2-1D). To investigate the role of
CaGIT1 in the utilization of GroPIns and GroPCho, a homozygous insertion mutant of
CaGIT1 was constructed using UAU methodology (73,74) to produce strain
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git1:UAU1/git1::URA3, as described in Materials and Methods. For insertional
complementation, plasmid pDDB78 (77) containing CaGIT1 pDDB78GIT1 was
linearized and transformed into git1:UAU1/git1::URA3 to produce
git1:UAU1/git1::URA3 + pDDB78GIT1. As evident in Fig 2-1A, insertional mutagenesis
of CaGIT1 abolished the utilization of GroPIns as a phosphate source on YNB plates,
while reintegration of CaGIT1 restored that ability. The plates shown were grown at
37C, but identical results were obtained at 30C. Also evident is that CaGIT1 is not
required for the utilization of GroPCho as a phosphate source.
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Figure 2-1. C. albicans utilizes GroPIns and GroPCho as sources of phosphate.
Strains pre-grown in 200 M KH2PO4 (low Pi) containing medium were harvested,
washed, and spotted in a series of 10x dilutions onto plates containing 200 M GroPIns
(A), 200 M GroPCho (B), 200 M KH2PO4 (C), or no phosphate (D). Data are
representative of multiple experiments.
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2.3.3 Uptake of label from [3H]inositol-GroPIns requires CaGit1 and is regulated by
phosphate availability. Since GroPIns and GroPCho can act as sources of phosphate, we
next monitored the ability of cells to take up label from [ 3H]inositol-GroPIns and
[3H]choline-GroPCho. Label uptake was monitored in cells grown YNB media
containing either high (10 mM KH2PO4) or low (0.2 mM KH2PO4) phosphate level (Fig.
2-2), as phosphate availability has been shown to regulate the expression of ScGIT1 (65).
The transport assays (2 min for GroPCho, 10 min for GroPIns) were optimized to ensure
that uptake was linear with time at the given substrate concentration. As shown in Fig. 22A, [3H]GroPIns uptake is completely absent in cells grown under high Pi conditions, and
the label uptake that occurs in cells grown in low P i medium requires CaGIT1. In
contrast, growth under high phosphate conditions decreased, but did not abolish, the
uptake of label from [3H]GroPCho (Fig. 2-2B). As expected, CaGIT1 played no role in
[3H]GroPCho uptake under high or low phosphate conditions.
Notably, uptake of label from [3H]GroPCho is quite robust, being roughly 50fold greater than that from [3H]GroPIns under low phosphate conditions. Furthermore, it
is roughly 500-fold greater than that observed in S. cerevisiae cells grown under low
phosphate conditions (compare Fig. 2-2B and 2-2C). In contrast, [3H]-GroPIns transport
is roughly the same in C. albicans as it is S. cerevisiae cells grown under low phosphate
conditions (compare Fig. 2-2A and 2-2C).
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Figure 2-2. [3H]GroPIns uptake requires CaGit1 and is regulated by phosphate
availability. (A and B) Strains grown in either 10 mM KH2PO4 (high Pi) or 0.2 mM
KH2PO4 (low Pi) containing media were harvested, washed, and assayed for either (A)
GroPIns transport in the presence of 5 M [3H]GroPIns or (B) GroPCho transport in the
presence of 200 M [3H]GroPCho, as described for the standard transport assays. (C) S.
cerevisiae transport was determined in the presence of 5 M [3H]GroPIns or
[3H]GroPCho, as described in material and methods. Values represent mean  S.E. of
triplicate determinations. Experiment was repeated with similar results.

27

2.3.4 Glycerophosphodiester utilization at physiological pH. In order to determine if
the observed growth on GroPIns and GroPCho might also occur under nonacidic
conditions that may be encountered in a human host, we monitored growth of the wild
type C. albicans strain at pH 7.5. We also compared the growth to that obtained for the
nonpathogenic S. cerevisiae (Fig. 2-3). As seen in Fig. 2-3A, C. albicans grew when 200
M of KH2PO4, GroPIns, or GroPCho were provided as the phosphate sources. Growth
on GroPCho was just as robust as when KH2PO4 was supplied as the phosphate source
after 24 and 48 h. Growth on GroPIns was somewhat slower, requiring 48 hours for the
cells to reach OD600 between 3 and 4. In contrast, S. cerevisiae grew at pH 7.5 when
KH2PO4 was supplied, but displayed little or no growth when GroPIns or GroPCho was
supplied (Fig. 2-3B). Thus, C. albicans is clearly more adept than S. cerevisiae at using
glycerophosphodiesters as phosphate sources at pH 7.5. Serum pH, typically between
7.3-7.5, is often referred to as physiological pH.
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Figure 2-3. C. albicans and S. cerevisiae vary in their ability to grow on
glycerophosphodiesters at physiological pH. Wild type C. albicans (DAY185) (A) and
S. cerevisiae (BY4741) (B) strains were grown in YNB medium buffered to pH 7.5,
containing 200 M GroPIns, 200 M GroPCho, or 200 M KH2PO4 as phosphate
sources, or containing no phosphate source. Values represent mean  S.E. of duplicate
determinations. Experiment was repeated with similar results.
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Figure 2-4. GroPIns and GroPCho utilization by C. albicans at pH 6.5 versus pH
7.5. (A and B) Strains were grown in either YNB medium at pH 6.5 or YNB medium
buffered to pH 7.5 containing (A) 200 M GroPIns or (B) 200 M GroPCho as sole
phosphate sources. (C and D) Strains grown in low P i YNB medium and low Pi YNB
medium buffered to pH 7.5 were harvested, washed, and assayed for either (C) GroPIns
transport in the presence of 5 M [3H]GroPIns or (D) GroPCho transport in the presence
of 200 M [3H]GroPCho, as described for standard transport assays. Values represent
mean  S.E. of duplicate determinations. Experiment was repeated with similar results.
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A direct comparison of the utilization of glycerophosphodiesters by C. albicans at
pH 6.5 versus pH 7.5 is shown in Fig. 2-4 A and B. These mildly acidic and mildly
alkaline conditions could both be encountered by C. albicans in a mammalian host. For
these experiments, cells were grown under low phosphate conditions. First, it is clear that
C. albicans reaches a lower optical density at pH 7.5 as compared to pH 6.5 when grown
on GroPIns (Fig. 2-4A). At the same time, [3H]GroPIns uptake at pH 7.5 is lessened by
approximately two-thirds when compared to cells grown at pH 6.5 (Fig. 2-4C), and is
dependent upon CaGIT1. Loss of CaGIT1 also results in the inability of cells to utilize
GroPIns as a phosphate source at pH 6.5 (Fig. 2-4A), as expected from the plate results
seen in Fig. 2-1. At pH 7.5, however, the growth that occurs on GroPIns after 48 hours is
primarily independent of CaGIT1. Thus, a CaGit1-independent mechanism exists for
scavenging phosphate from GroPIns at pH 7.5.
Interestingly, Fig. 2-4B shows that C. albicans grows equally well at pH 6.5 as at
pH 7.5 when GroPCho is supplied as the phosphate source. At both pH 6.5 and pH 7.5,
growth on GroPCho is independent of CaGIT1 (Fig. 2-4B). Although uptake of label
from [3H]GroPCho into cells grown at pH 7.5 is decreased by about one-third compared
to those grown at pH 6.5 (Fig. 2-4D), it is still quite high. These experiments were
performed at 30C, because the filamentation that occurs at pH 7.5 and 37C causes the
cells to flocculate and makes it difficult to get accurate optical density readings and
repeatable transport assays. However, the following major findings were repeated at 37C
(data not shown): i) CaGIT1 is required for liquid growth on GroPIns at pH 6.5. and ii)
CaGIT1 is not required for growth on GroPCho at either pH 6.5 or pH 7.5.
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2.3.5 GroPIns kinetics, specificity, and proton dependence. Since our data indicated
that CaGit1 is a transporter for GroPIns, but not GroPCho, we focused the remainder of
our studies on characterizing GroPIns transport through CaGit1. For analyzing the kinetic
parameters and specificity of [3H]inositol-GroPIns uptake, cells were grown under low P i
conditions on unbuffered YNB medium, the conditions under which GroPIns transport
was shown to be greatest. Uptake of label from [ 3H]inositol-GroPIns conformed to
Michaelis-Menton kinetics (Fig. 2-5), as expected for saturable carrier-mediated
transport. The apparent Vmax for GroPIns transport was 960 ± 70 pmoles/min/ODU and
the apparent Km = 28 ± 6 µM. This compares well with the apparent Km determined for
GroPIns transport by ScGit1 (ca. 20 µM) (85). Transformation of the data (Fig. 2-5B)
into a Hanes plot (80) results in a straight line, suggesting a single transport system under
the conditions tested. These results provided added confidence that the observe label
uptake from [3H]GroPIns was indeed the result of “transport”.
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Figure 2-5. Kinetics of GroPIns transport. (A) Strain grown in 0.2 mM KH2PO4 (low
Pi) containing media were harvested, washed, and assayed for GroPIns transport in the
presence of concentrations between 1 M to 100 M [3H]GroPIns in 100 mM citrate
buffer, pH 5.0, as described in text. Substrate uptake was plotted against initial
concentrations of GroPIns. Data were linearized (B) using a Hanes plot transformation.
Values represent mean  S.E. of duplicate determinations. Experiment was repeated with
similar results.
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We next tested the transport specificity of CaGit1 by performing competition
experiments. For these experiments, a 40-fold excess of unlabeled compounds was added
to the transport assay and the effect upon GroPIns transport activity monitored (Fig. 26A). Compounds able to compete with GroPIns for transport through CaGit1 or to bind
to the permease with some specificity should decrease transport activity. As expected, an
excess of unlabelled GroPIns decreased the transport activity (Fig. 2-6A). Interestingly,
glycerol-3-phosphate (GroP) also decreased transport activity. This finding suggested that
GroP was transported by CaGit1, or that it bound to CaGit1 with enough affinity to
inhibit GroPIns transport, but that it was not transported by CaGit1. To address these
possibilities, we first performed [3H]glycerol-GroP transport assays using our standard
GroPIns transport conditions (data not shown), but were unable to detect any activity.
Next, we monitored the ability of C. albicans to utilize GroP as a phosphate source, and
found that it does, but that the growth is not dependent on CaGIT1 (Fig. 2-6C). Thus, the
most likely interpretation of these experiments is that GroP can compete with GroPIns for
binding to CaGit1, but that GroP is not transported to an appreciable extent by CaGit1.
Since GroP can clearly act as a phosphate source for C. albicans, there must be another
mechanism for its utilization. Two possibilities are that GroP has a transporter distinct
from CaGit1, or that GroP is hydrolyzed extracellularly to free phosphate and glycerol
before being used as a phosphate source.
GroPIns transport was not affected by an excess of either unlabeled inositol or
unlabeled phosphate, indicating that those compounds have little or no affinity for the
permease. In particular, the fact that excess unlabeled inositol did not decrease label
incorporation from [3H]inositol-GroPIns is evidence that our transport assays measure
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Figure 2-6. Specificity and proton dependence of GroPIns transport. (A and B) Wild
type strain (DAY185) was grown in low Pi YNB medium to logarithmic phase,
harvested, washed and assayed for transport activity in the presence of the indicated
compounds at 1 mM for GroPIns, GroP, inositol, sodium phosphate, and 50 M for
CCCP (A) or as a function of increasing pH (B), as described in text. (C) Strains grown
in low Pi media were harvested, washed and spotted in a series of 10x dilutions onto
plates containing onto 200 M GroP. Values for (A) and (B) represent mean  S.E. of
duplicate determinations. Experiments were repeated with similar results.
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intact [3H]inositol-GroPIns transport, and not the uptake of free [ 3H]inositol following
hydrolysis of [3H]inositol-GroPIns outside of the cell.
If CaGit1 is a proton symporter, as predicted by in silico analysis (69), the
protonophore, carbonyl cyanide 3-chlorophenylhydrazone (CCCP), should drastically
reduce GroPIns transport activity, and it did (Fig. 2-6A). In addition, if proton-motive
force is important to transport, altering the pH of the assay buffer should affect transport
activity. As shown in Fig. 2-6B, GroPIns transport activity decreased with increasing pH,
consistent with CaGit1 being a proton symporter.

2.3.6 Depletion of GroPIns from the medium corresponds to the presence of CaGit1
and intact GroPIns detected intracellularly. Further evidence for the transport of
GroPIns across the plasma membrane was obtained by monitoring the levels of the
metabolite in the medium by liquid chromatography-mass spectroscopy (LC-MS) as a
function of growth. At time zero, cultures were spiked with 200 µM GroPIns, and after 6
and 24 h of growth, the GroPIns remaining in the medium was monitored by LC-MS
(Fig. 2-7). The levels of GroPIns in the medium of the wild type strain and the
homozygous insertion mutant bearing a reintegrated copy of CaGIT1 decreased with time
(Fig. 2-7A) and cell growth (Fig. 2-7B). In contrast, the homozygous git1-/git1- grew
very little, and there was no decrease in the GroPIns peak. The fact that the levels of
GroPIns in the medium remained the same in the git1-/git1- mutant is another indication
that extracellular hydrolysis of the compound does not occur under these conditions.
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Figure 2-7. Depletion of GroPIns from the medium as a function of growth. (A) The
indicated strains were inoculated in YNB medium lacking KH2PO4 that contained 200
M GroPIns. The GroPIns concentration in the medium was determined by LC-MS after
0, 6, and 24 h. Values represent mean  S.E. of triplicate determinations. (B) Growth
curves of the strains.
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As final confirmation that GroPIns is transported intact into the cell, we analyzed
the labeled compounds in the intracellular fraction of the cell following a short-term
transport assay with [3H]inositol-GroPIns. The internal water-soluble counts were
extracted, separated, and identified, and the amount of label present in the particulate
membrane fraction of the cell was also determined. Importantly, we detected intact
[3H]GroPIns as 21% ± 6% of the internalized label. In addition, we detected free
[3H]inositol (69% ± 6% ), as would be expected if GroPIns is rapidly hydrolyzed once it
enters the cell. Finally, we also detected 11% ± 2% of the label in the membrane
fraction, presumably in phosphatidylinositol or the inositol containing sphingolipids
derived from phosphatidylinositol.

2.3.7 CaPHO4 is required for GroPIns transport, utilization, and expression. In
order to gain insight into the transcriptional regulation of CaGIT1, a library of
transcription factor mutants (78) was screened. A total of 143 strains, each bearing
homozygous deletions in a single transcriptional regulator, were assayed for growth when
GroPIns was supplied as the phosphate source. Only one strain, that bearing a deletion in
CaPHO4, displayed a clear inability to grow on GroPIns (Fig. 2-8A). The deletion set
contained two isolates of each strain, and both isolates behaved identically. The pho4/
mutants were able to grow on GroPCho, although slightly less well than the wild type
(Fig. 2-8A). Note that little or no background growth was seen in the pho4/ mutant
compared to the wild type strain when no phosphate source was provided. This result is
likely due to the fact that CaPHO4 is required to induce genes involved in mobilization
of internal stores of phosphate and phosphate scavenging when phosphate is limiting, as
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is the case with S. cerevisiae (86,87). As expected, transport assays confirmed that little
or no transport activity exists in either pho4/ mutant isolate (Fig. 2-8B). RT-PCR gene
expression analysis was also performed on both pho4/ isolates and the reference wild
type (Fig. 2-8C). These results confirm that CaPho4 is required for CaGIT1 expression.
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Figure 2-8. Effect of PHO4 deletion on growth and transport activity. (A) The wild
type strain and a pho4/ deletion mutant were spotted in a series of 10x dilutions onto
plates containing the indicated sources of phosphate at a concentration of 200 M. A
second pho4/ isolate gave identical results. (B) Uptake activity of the wild type and
the two pho4/ deletion mutant isolates. Values represent mean  S.E. of triplicate
determinations. Experiment was repeated with similar results. (C) Expression of CaGIT1
in the pho4/ mutant and reference wild type. Strains were grown on synthetic YNB
supplemented with 200M (low Pi) or 10mM (high Pi) KH2PO4 . RNA was extracted and
expression measure by quantitative real time-PCR analysis. Values were normalized to
the CaTDH3 control and to 1. Values represent the mean of triplicate determinations ±
SE, where applicable.
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2.4 Discussion
Fungal cells scavenge nutrients from the environment to support their cellular
activities. Potential nutrients can arise through the organism’s own cellular activities or
may be provided by the host environment. The glycerophosphodiesters produced through
phospholipase-mediated hydrolysis of phospholipids are utilized by the non-pathogenic S.
cerevisiae as sources of phosphate, inositol, and choline (30,65,66). Here we have
shown that the pathogenic organism, C. albicans, is also capable of transporting and
utilizing glycerophosphodiesters as nutrients, but a number of differences between the
organisms are evident.
Whereas a single transporter is responsible for both GroPIns and GroPCho
transport in S. cerevisiae (67), our data indicate that at least two glycerophosphodiester
transporters exist in C. albicans, with CaGit1 being a GroPIns permease. CaGit1 is
required for the utilization of GroPIns as a phosphate source on standard YNB solid and
liquid medium at pH 6.5. In addition, CaGit1 is required for GroPIns transport when cells
are grown at both acidic (pH 6.5) and physiological pH (pH 7.5). The increased transport
activity seen at lower pH is consistent with a recent paper in which high throughput
sequencing of cDNA revealed much greater expression of CaGIT1 at pH 4 as compared
to pH 8 (88). Although no GroPIns transport activity occurs in the absence of CaGit1, C.
albicans is still able to use GroPIns as a phosphate source at pH 7.5, albeit slowly. Thus,
a second, CaGit1-independent, mechanism must exist for utilizing GroPIns as a
phosphate source at physiological pH. That mechanism may involve an unidentified
transport activity with slow enough kinetics that it was not detected under the short-term
transport assay employed here or, perhaps, external hydrolysis of GroPIns to liberate free
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phosphate. Indeed, starvation for phosphate is known to induce the production of
extracellular phosphatases and phosphoesterases for hydrolyzing and scavenging
phosphate in S. cerevisiae (86,87), although none that hydrolyze GroPIns have been
identified. Note that the extracellular liberation and subsequent transport of free
phosphate that could theoretically occur at pH 7.5 would not be detected in our uptake
assays, as the phosphate group of [3H]inositol-GroPIns is not labeled.
Several lines of evidence support the notion that GroPIns is transported intact
across the plasma membrane via CaGit1, even though a second, CaGit1-independent,
mechanism also exists for acquiring phosphate from GroPIns at pH 7.5. First,
competition assays indicate that neither free inositol nor free phosphate, potential
hydrolysis products of GroPIns, have significant affinity for the permease. Although
GroP, another potential hydrolysis product of GroPIns, did compete for transport activity,
we were unable to detect GroP transport (data not shown), and the ability of GroP to
support growth was not dependent on CaGIt1. Thus, GroP likely has affinity for the
transporter, but is not a substrate for it. Second, the ability of cells to utilize GroPIns as a
phosphate source correlates with the depletion of the compound from the medium as
measured by LC-MS. Importantly, the LC-MS data also shows that GroPIns is stable in
the medium at pH 6.5, since GroPIns levels did not change, even after 24 h of incubation
in medium inoculated with a git1-/git- mutant. Finally, we detected intact GroPIns in the
intracellular fraction of the cell following a short-term transport assay.
Several aspects of uptake of label from [ 3H]GroPCho by C. albicans are worth
noting. First of all, uptake of label from [ 3H]GroPCho is much greater (approximately
50-fold) than that from [3H]GroPIns. Also, when comparing uptake between S. cerevisiae
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and C. albicans, an enormous difference exists, with the activity of C. albicans being
approximately 500-fold greater when the organisms are grown under identical growth
conditions. The fact that C. albicans has three remaining ORFs with high similarity to
CaGit1 leads to the possibility that one or more of those may be involved in GroPCho
transport. It is also possible that other, unidentified, transporters are involved.
Not unexpectedly, phosphate levels regulate GroPIns transport activity, as they do
in S. cerevisiae (89). In addition, we identified CaPHO4, a homolog of ScPHO4, as being
required for the transport and utilization of GroPIns as a phosphate source. The pho2/
mutant was not picked up in our screen, and it was not required for growth on GroPIns
when tested individually (data not shown). In S. cerevisiae, ScPHO2 and ScPHO4 are
both involved in the transcriptional regulation of a number of phosphate-responsive genes
(86,87), including ScGIT1. However, others have shown that CgPHO2 is not important
for the transcriptional response to low phosphate in Candida glabrata and, specifically,
for the induction of the C. glabrata homolog of GIT1 (90). Interestingly, a paper in which
the property differences of the major clades of C. albicans were investigated found an
association between phosphate-related metabolism and virulence (91). Specifically,
CaGIT1 (numbered orf19.34, but not named in the paper) was one of 18 genes, 5
involved in phosphate metabolism, whose expression profile differed significantly
between isolates of high, medium, and low virulence (91), being the highest in the most
virulent strains.
Our results show that C. albicans has an expanded ability to transport and utilize
glycerophosphodiesters, as compared to S. cerevisiae. Notably, C. albicans is able to use
GroPIns and GroPCho as phosphate sources at both acidic and physiological pH (the
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approximate pH of serum, pH 7.5), whereas S. cerevisiae does so only marginally at pH
7.5. This fact gains importance when considering that C. albicans may be exposed to a
range of pHs, from acidic to alkaline, in its mammalian host (92,93). In fact, when
considering the gastrointestinal tract alone, pH can vary from pH 2 in the stomach, to pH
6-7.4 in the intestine and terminal ileum, to pH 6.7 in the rectum (93). The vagina is also
considered to be an acidic environment. Finally, human saliva can range from pH 6.5 pH 7.5 (94). Thus, our focus on mildly acidic (pH 6.5) and mildly basic (pH 7.5)
conditions is relevant to conditions that could be encountered during infection. Another
expansion of abilities when comparing glycerophosphodiester utilization between the two
organisms is not only that GroPIns and GroPCho utilization occurs via separate
mechanisms in C. albicans, but that those mechanisms are regulated differentially by
both pH and phosphate availability. Like pH, phosphate levels are likely to vary in the
human host. For example, while phosphate levels in a healthy human serum are normally
between 0.8-1.45 mM, those levels can drop to 0.3 mM and lower (the low phosphate
range for the experiments performed here), depending upon diet and various disease
states that induce hypophosphatemia (95). Taken together, our findings lead us to
speculate that the expanded ability of C. albicans to utilize GroPIns and GroPCho results
from the organism’s pathogenic nature and its need to occupy a variety of environments
within its host organism. This possibility is buttressed by the fact that GroPIns and
GroPCho are present and abundant in human fluids, as mentioned in the introduction
(48,56-64).
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Future studies will focus on identifying the transporter/s responsible for GroPCho
utilization and on determining the importance of glycerophosphodiester metabolism on
C. albicans virulence and survival in a mammalian host.
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Transport and Metabolism of Glycerophosphocholine by
Candida albicans: Role of CaGit3, CaGit4, and CaGde1
Andrew C. Bishop, Shantanu Ganguly, Benjamin M. Cooley, Aaron P. Mitchell and
Jana Patton-Vogt
Chapter 3 Attributions
I did all of the work in this chapter expect those noted here.
Shantanu Ganguly, a graduate student in Dr. Aaron Mitchell’s laboratory, constructed
the strains git3∆/∆ (JPV 662/SGH319) and git4 (JPV 665/SGH320). He also constructed
the strain git2-4∆/∆ (JPV692/SGH338), which I used to constructed strains git24∆/∆+pDDB78 (JPV707), git2-4∆/∆ +pDDB78GIT2 (JPV754), git2-4∆/∆
+pDDB78GIT3 (JPV737), and git2-4∆/∆+pDDB78GIT4 (JPV756).
Benjamin Cooley, an undergraduate student in Dr. Patton-Vogt’s laboratory, aided me in
sample processing of [3H]Choline-metabolites by ion-exchange chromatography.

3.1 Introduction
Candida albicans is an opportunistic fungal pathogen that is part of the natural
flora of healthy human beings (96). C. albicans is also the most common cause of
hospital related fungal infections. ICU patients and individuals with compromised
immune systems are most likely to be affected due to cancer treatments,
immunosuppressant therapy, or diseases like HIV (14,15). It is well known that
pathogenic organisms develop strategies to survive and proliferate in the host. One
strategy known to influence fungal virulence is the secretion of phospholipases (26,29). It
is thought that phospholipases may enhance virulence by damaging the host membranes
(26), but their importance may also be related to their ability to release metabolites that
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can be used as nutrients. C. albicans contains five phospholipase B (PLB) encoding
genes (29) and disruption in CaPLB1 or CaPLB5 has been shown to attenuate virulence
(31,53). PLBs catalyze the hydrolysis of both fatty acyl esters on phospholipids to
produce both free fatty acids and water-soluble lipid metabolites, called a
glycerophosphodiesters (26,30).
We have reported that C. albicans transports glycerophosphodiesters, specifically
GroPIns and GroPCho, into the cell where they are hydrolyzed and used as a source of
phosphate, choline, and inositol (97). CaGIT1, identified based on sequence similarity to
S. cerevisiae GIT1, was shown to be responsible for GroPIns transport. Initial GroPCho
transport in C. albicans is roughly 50 times greater than that of S. cerevisiae and 3 other
ORFs (CaGIT2-4; 19.1978-19.1980) with similarity to CaGIT1 exist in the C. albicans
genome (97). CaGIT2-4 lie in a tandem repeat on chromosome 5 and, like CaGIT1, are
members of the H+ phosphate family of the major facilitators superfamily (MSF) (69).
While S. cerevisiae has two members of this family, ScGit1 and ScPho84, C. albicans
has five members, CaPho84 and CaGit1-4. The elaboration of this transport family in C.
albicans may be related to the presence of glycerophosphodiesters in the human host.
Phospholipid metabolites, including glycerophosphodiesters, have been located
throughout mammalian tissues and fluids (48,56-63,98). GroPCho and its precursor,
phosphatidylcholine, are prevalent in serum (61,98). They have also been located in the
gastrointestinal tract and the urinary tract (57-60), two places where C. albicans is known
to colonize (96,99). GroPCho is present in renal medullar of the kidney, where it serves
as a protective osmolyte against high concentration of NaCl and Urea (56), and where
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there is risk of C. albicans infection in critically ill patients (96). Additionally GroPCho
is found in the brain and spinal fluid (62,63).
In this study, we have further characterized GroPCho transport and metabolism in
C. albicans. We have identified CaGit3 and CaGit4 as GroPCho transporters, with
CaGit3 exhibiting the major activity. In addition, we have identified CaGde1 as a
glycerophosphodiesterase involved in intracellular GroPCho catabolism. Our findings
also provide evidence that GroPCho utilization by C. albicans occurs under conditions
that may be encountered in the human host.

3.2. Material and Methods
3.2.1 Strains and media. C. albicans strains used in this study can be found in Table 3-1.
Strains were grown aerobically at 30°C unless otherwise noted. Turbidity was monitored
by measurement of absorbance at 600nm (A600) on a Biomate 3 Thermo Spectronic
spectrophotometer. Media used for this study was synthetic complete (yeast nitrogen base
[YNB]) containing 2% glucose, which has previously been described (72). Media
phosphate concentrations were controlled by removing KH2PO4 (1g/L) from the synthetic
mix and replacing it with KCl (1 g/L). KH2PO4 was then added back into media at high
(10mM) or low (200M) concentrations as indicated. In some experiments, media
contained GroPCho (200M) (Sigma no. G5291). For all experiments, media was
supplemented with 80 g/ml uridine. For serum experiments, bovine serum (Sigma no.
B9433) was added to synthetic complete YNB media containing KH2PO4 (1mM) at 10%
of the total volume. Strains were maintained on YEPD agar plates (yeast extract 10g,
peptone 20g, dextrose 10g per liter) at room temperature.
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3.2.2 Construction of homozygous mutants. Primers used in this study are listed in
Table 3-2. The wildtype strain (DAY185) and methodology for creating homozygous
deletion mutants have been previously described (75,100). In general, a forward deletion
primer consisted of 100 nt homologous to the upstream region of the gene's start site plus
an adaptor sequence (5' -TTTCCCAGTCACGACGTT-3') that flanked the 5' end of the
URA3 gene in plasmid pGEM-URA3 (JVE 278) (75). A reverse deletion primer consists
of 100 nt of homology downstream of a gene's stop site plus an adaptor sequence (5' GTGGAATTGTGAGCGGATA-3') that flanked the 3’ end of the URA3 gene in plasmid
pGEM-URA3. The 1.4 kb PCR product, was transformed into strain BWP17 and Ura +
transformants were selected. Identical primers were used to PCR amplify the ARG4 gene
from plasmid pRS-ARG4 (JVE279) (75) for deletion of the second allele since the same
adaptor sequence was contained in both plasmids pGEM-URA3 and pRS-ARG4. The
approximately 2.5 kb PCR product containing the ARG4 gene, was transformed into the
heterozygous mutant strain and Ura+ Arg+ transformants were selected. A homozygous
deletion mutant would produce PCR products for both the inserted URA3 gene (1.2 kb)
and inserted ARG4 gene (2.3 kb), but not the native locus. For two strains (git3/ and
git4/), homozygous deletions were made utilizing the URA3 cassette described above,
but following heterozygous mutant verification, 5-fluoroorotic acid (5-FOA) counter
selection was performed (100). The URA3 cassette was again transformed into the
heterozygous mutant strain, deletion of the second native allele was verified, and counterselection on 5-FOA was repeated producing a Ura- homozygous deletion mutant.
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Table 3-1. Strain Table Chapter 3
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Table 3-2. Deletion Primer Sequences

Table 3-3. Complementation Primer Sequences

Table 3-4. Quantitative RT-PCR Primer Sequences
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3.2.3 Construction of complementation plasmids. Complementation plasmids were
constructed for CaGIT2, CaGIT3, CaGIT4, and CaGDE1 using plasmid pDDB78 (100).
Each target gene was amplified from genomic DNA using primers that can be found in
Table 2B. Each forward primer was located approximately 1500bp upstream from the
start site and contained a 5' Not I restriction site plus 100 nt of homology to the genomic
DNA. The reverse primer was located approximately 300 bp downstream of the stop site
and contained a 5' EcoR I restriction site plus 100 nt of homology to the genomic DNA.
Upstream and downstream locations varied depending on intergenic distances and
neighboring ORFs. The vector pDDB78 was linearized with restriction enzymes Not I
and EcoRI. The linear pDDB78 and amplified target gene were transformed into S.
cerevisiae BY4741 strain (trp1∆63, his3∆200, ura3-52, leu2∆1) (JPV1) (100) for in-vivo
recombination and Trp+ colonies were selected. Plasmids were extracted from Trp +
colonies using the acid washed beads and a Zyppy Mini prep kit (Zymo). Extracted
plasmids were then transformed into E. coli and Amp+ plasmids were selected. The
plasmids were extracted from E. coli and verified by PCR and agarose gel
electrophoresis.

3.2.4 Insertional complementation of deletion mutants. Plasmids pDDB78GIT2,
pDDB78GIT3, pDDB78GIT4, and pDDB78GDE1 were linearized with Nru I, which cut
the plasmids within the HIS1 gene. Linearized pDDB78GIT2, pDDB78GIT3 and
pDDB78GIT4 plasmids were then transformed into git2-4/ (JPV 692/SGH338) and
linearized pDDB78GDE1 was transformed into gde1/ (JPV 733) for recombination at
the HIS1 locus. His+ transformants were tested for complementation of the mutant
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phenotype when possible. Complementation was also verified by PCR. Empty plasmid
pDDB78 was also linearized and transformed into both git2-4/ and gde1/ strains.

3.2.5 Short term [3H]GroPCho transport assays. Short-term transport assays were
performed as previously described (97). Briefly, cultures were grown to log phase at
30°C. Aliquots were harvested, washed 1X in sterile DI H2O and suspended in 100 mM
citrate buffer (pH 5) to an A600 of 5. Cell suspensions were incubated at 30°C for 10
minutes with agitation to allow for equilibration to buffer conditions. The assay was
started by the addition of 50 l of 1 mm [3H]GroPCho to 200 l of cell suspension
making a final concentration of 200 M [3H]GroPCho. After 2 minutes of incubation at
30°C, the assay was stopped by the addition of 10ml ice-cold DI H2O. The samples were
immediately filtered through glass fiber (GF/C) filters (Whatman no 1822-025). The
filters were washed 1X with ice-cold DI H2O and suspended in 10ml of scintillation fluid.
Radioactivity was measured by liquid scintillation counting. Tritium-labeled GroPCho
([3H]choline-GroPCho) was produced through the chemical deacylation of phosphatidylmethyl-[3H]choline (American Radiolabaled Chemicals) as previously described (79).
To determine GroPCho transport kinetics, transport assays were performed as
described above. Assays were started with the addition of 50 l [3H]GroPCho ranging in
concentrations from either 20 M to 1 mM or 5 M to 200 M depending on which
GroPCho transporter was being assayed (See Figure 3-6). Saturation kinetics data for
GroPCho were analyzed to determine estimated Km and Vmax using Levenberg-Marquardt
algorithm for nonlinear regression in GraphPad Prism (version 4.0). Values were
determined by least squares fitting of the data to the Michaelis-Menten equation (V =
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Vmax[S]  (Km + [S])-1), where S represents GroPCho. Linearization of kinetics data was
performed using Hanes plot transformations (80).

3.2.6 Preparation of external and internal cellular fractions and analysis of
[3H]choline-containing metabolites by ion-exchange chromatography. [3H]cholinecontaining metabolites were analyzed in both intracellular and extracellular fractions of
the cell following short-term transport assays and long-term incorporation studies. For the
short term studies, a standard 2 minute transport assay was performed except that the
assay was not stopped with 10 ml of DI H2O. Rather, 750 l of H2O was added to the 250
l cell suspension. The cells were pelleted and the supernatant was removed as the
extracellular fraction. The pellet was washed 1X in 500 l of DI H2O and pelleted. The
supernatant was again removed to the extracellular fraction.
To isolate an internal fraction (81) the cell pellet was suspended 100 l of 5%
TCA solution followed by 10-minute incubation on ice. Cells were again pelleted and the
supernatant was removed as the internal fraction. To neutralize the TCA, equal volume
of 1 M Tris (pH 8) was added to the TCA fraction. The cell pellet was washed 1X with
300 l of DI H2O and the supernatant was added to the internal fraction.
Long-term incorporation studies were designed to analyze label uptake
incrementally over 24 hours. The assay was started by inoculating 2.2 ml cultures of
synthetic complete YNB media containing 200 M KH2PO4 and 50 M [3H] GroPCho to
an A600 of 0.05. At 6, 12, 18, and 24 hours after inoculation, 400 l of culture was
removed. Cells were pelleted and the extracellular fraction was removed. When
necessary, non-radioactive cells were added to aid in the pelleting of radioactive cells.
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Pellets were washed with 600 l of DI H2O and again pelleted. The pellet was suspended
100 l of 5% TCA solution followed by 10 min incubation on ice. Cells were again
pelleted and the TCA fraction was removed as the internal fraction. To neutralize the
TCA, equal volume of 1M Tris (pH 8) was added to the TCA fractions. The cells were
washed 1X with 300 l DI H2O, pelleted and the supernatant was removed to the internal
fraction. Internal and external samples were diluted 4X in DI H 2O, applied to 250 l
Dowex 50W8, 200-400 anion exchange columns, and eluted as described previously
(101). Briefly, [3H]GroPCho was eluted with 2X 1 ml H2O washes. [3H]Cholinephosphate, if present, was eluted with a subsequent 1 ml H2O wash. [3H]choline was
eluted with 5 ml of 1 M HCl. Standards were used to verify that columns were
functioning correctly. Radioactivity in each sample was determined using liquid
scintillation counting.

3.2.7 RNA extraction and gene expression analysis by quantitative Real Time-PCR.
RNA extraction and quantitative RT-PCR procedures were performed as described
previously (97). Briefly, strains were grown in low (200 M) or high (10 mM) phosphate
media described above. Cultures were grown to A600 between 0.8 and 1.2, harvested, and
RNA was extracted using a hot-phenol chloroform extraction (82). RNA was DNase
treated using the Turbo DNA- Free kit (Applied Biosystems) and stored at -80oC until
analysis. Primer 3 software (http://frodo.wi.mit.edu/primer3/) was used to design forward
and reverse qRT-PCR primers for CaTDH3, CaGIT3, CaGIT4, and CaGDE1 (Table 32C). Quantitative RT PCR was carried out on an Applied Biosystems StepOnePlus
instrument using Power SYBR green RNA to CT 1 Step Kit (Applied Biosystems). Each
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reaction consisted of 0.2 l of a 125X RT enzyme mix, 12.5 l of 2X RT-PCR mix, 1
M primers, and 1.5 l of DNase treated RNA brought up to a volume of 25 l with
DEPC treated H2O. Experimental samples were performed in triplicate and are
representative of 3 independent determinations. Reverse transcription was performed at
50oC for 15 min, followed by 95 oC for 15 min for RT inactivation and polymerase
activation. This was followed by 40 cycles of 95 °C for 15 s, 50°C for 30s for primer
annealing and 72°C for 40s for amplification. Melt curve analysis was used to check for
product specificity. Control reactions without reverse transcriptase were also performed.
Expression levels were analyzed using the CT method (84) and normalized to the
endogenous control, CaTDH3. For experiments determining the change in expression due
to phosphate concentrations, wild type (DAY185) low phosphate expression was
normalized to 1 and used to compare fold change in high phosphate expression. For
experiments determining the change in expression due to CaPHO4, wild type (WT-TF)
low phosphate expression was normalized to 1 and used to compare fold change in the
pho4/ strain under low phosphate conditions.

3.2.8 [3H] GroPCho uptake in serum and XTT cell proliferation assay. Parallel
radioactive and non-radioactive experiments were performed. Non-radioactive cultures
were used to assess cell growth using the XTT cell proliferations assay kit (Abnova).
This assay measures the reduction of XTT (2,3-bis-(2-methoxy-4-nitro-5-sulfophenly)-5[(phenylamino) carbonyl]-2H-tetrazolium hydroxide) through the production of a
colorimetric product and was previously used to monitor cell proliferation in C. albicans
biofilm growth (102). Cultures (1ml) of synthetic complete media (1mM KH 2PO4)
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containing 10% bovine serum were inoculated to an A600 of 0.1. For the radioactive
samples the media was supplemented with 200 M [3H] GroPCho, while 200 M
GroPCho was used in the non-radioactive samples. Cultures were grown at 37°C with
agitation for 6 hours. Following the incubation period, the radioactive samples were
centrifuged at 3500 rpm for 4 min to pellet the cellular mass. The 1ml supernatant was
carefully removed as the extracellular fraction. Pellets were washed with 500 l of DI
H2O and centrifuged again removing the supernatant to the extracellular fraction. The
pellet was suspended 100 l of 5% TCA solution followed by 10 min incubation on ice.
Cells were again pelleted and the TCA fraction was removed as the internal fraction. To
neutralize the TCA, equal volume of 1M Tris (pH 8) was added to the TCA fractions.
The cells were washed 1X with 300 l DI H2O, pelleted, and the supernatant was
removed to the internal fraction. Internal [3H]choline-containing metabolites were
separated by ion-exchange chromatography as described in materials and methods.
Cell growth was assessed in non-radioactive cultures using the XTT kit since the
presence of serum induced hyphae formation and clumpy cells whose growth could not
be monitored by measuring optical density. After the 6 hours of growth, 10 l of XTT
reagent mix was added to each 1ml culture and carefully mixed with a pipette. Tubes
were incubated upright at 37oC for 4 hours. Tubes were centrifuged at 3500 rpm for 4
min to pellet cells and 50 l of supernatant was diluted 10 fold in DI H2O. Absorbance
was measured at 450 nm and this number was used to normalize radioactive uptake of
[3H] GroPCho to approximate cellular growth across the different strains.
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3.3 Results
3.3.1 Novel construction of a CaGIT2-4 mutant. C. albicans contains 4 ORFs
(CaGIT1-4) that are predicted to be involved in glycerophosphodiester transport.
Previously we reported that CaGIT1 (ORF19.34) codes for a permease, CaGit1, that is
solely responsible for the uptake of glycerophosphoinositol (GroPIns), but does not have
specificity for GroPCho, a highly transported metabolite in C. albicans (97). Of the four
ORFs, CaGIT1 is the most similar to ScGIT1 and lies on chromosome 2. The remaining
three ORFs, CaGIT2-4, lie in a tandem repeat on chromosome 5 and are the focus of this
work. We compared CaGIT2-4 to each other using NCBI BLAST (103) on the Candida
Genome Database (CGD, www.candidagenome.org). Pairwise alignment of CaGit3 with
CaGit2 results in a 75.3% identity match and 86.8% positive match with no gaps.
Alignment of CaGit3 with CaGit4 results in a 73.7% identity match and 83.3% positive
match with no gaps. Alignment of CaGit2 with CaGit4 results in a 70.3% identity match
and 81.5% positive match with no gaps. Since all three ORFs are very similar to each
other, we reasoned that single mutation phenotypes might be difficult to detect because of
compensation by the other remaining ORFs. Using methodology described in materials
and methods, the region from CaGIT2 to CaGIT4 spanning roughly 8500 bp was deleted
from the genome. To the best of our knowledge this is the first report of a triple mutant
created by knocking out 3 genes in tandem.
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Figure 3-1. Both CaGIT3 and CaGIT4 can rescue growth of a git2-4Δ/Δ mutant
utilizing GroPCho as sole phosphate source. Strains were grown in synthetic YNB
liquid media lacking a phosphate source (C), supplemented with 200M KH2PO4 (B), or
with 200M GroPCho (A). Cultures were incubated at 30oC with shaking and A600
readings taken incrementally over 48 hours. Values represent mean ± standard error (SE)
of triplicate determinations. Strains are WT-DAY185 or git2-4/, which was
reintegrated with an empty vector (pDDB78), CaGIT2 (pDDB78GIT2), CaGIT3
(pDDB78GIT3), or CaGIT4 (pDDB78GIT).
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3.3.2 Role of CaGIT3 and CaGIT4 in the utilization of GroPCho as a phosphate
source. A strain bearing a homozygous deletion of CaGIT2-4 displayed altered growth
when GroPCho was provided as the sole phosphate source (FIG 3-1A). Early growth
(<12 hours post inoculation) was abolished, although growth did resume roughly 12-18
hours post inoculation by a mechanism independent of CaGIT2-4. Reintegration of either
CaGIT3 or CaGIT4 into the genome of git2-4/ rescued this early growth defect on
GroPCho, while reintegration of CaGIT2 and the empty vector (pDDB78) did not. All
strains grew uniformly when KH2PO4 was supplied (FIG 3-1B) and only background
growth was observed in the absence of a phosphate source (FIG 3-1C).

3.3.3. CaGit3 is the major GroPCho permease and is regulated by phosphate
availability. Since CaGIT3 and CaGIT4 rescued the growth defect observed in a git24/ strain, we next monitored the initial uptake of [ 3H]GroPCho in short-term assays.
We showed previously that [3H]GroPCho uptake was regulated by phosphate availability
(97), therefore cells were pre-grown in synthetic media containing either 200 M (Low)
or 10 mM (High) KH2PO4. Short-term (2 min) initial transport assays were performed.
Reintegration of CaGIT3 rescued a majority of the activity lost by the deletion of
CaGIT2-4 (FIG 3-2A). Reintegration of CaGIT4 also rescued initial [3H]GroPCho
transport, albeit at a much lower level than CaGIT3. However, on an adjusted scale (FIG
3-2B) it is evident that [3H]GroPCho uptake through CaGit4 is not trivial, but is
comparable to [3H]GroPIns uptake by CaGit1 that is observed in a wild type strain (97).
As shown in Table 3-5, growth in high phosphate reduces the mRNA levels of CaGIT3
and CaGIT4 as determined by quantitative RT-PCR.
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Figure 3-2. GroPCho transport is regulated by phosphate availability. CaGit3
displays a greater initial GroPCho uptake than CaGit4. A) Strains grown to log
phase in synthetic YNB media containing either 200M KH2PO4 (L) or 10mM KH2PO4
(H) were harvested and assayed for their ability to transport [ 3H]GroPCho in 2 min
assays. B) Enlargement of git2-4/ + pDDB78GIT4 (L) from A compared to uptake of
[3H] GroPIns by WT-DAY185 strain grown under low phosphate conditions. Values
represent mean ± standard error (SE) of triplicate determinations. Strains are WTDAY185 or git2-4/, which was reintegrated with an empty vector (pDDB78), CaGIT2
(pDDB78GIT2), CaGIT3 (pDDB78GIT3), or CaGIT4 (pDDB78GIT).
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Table 3-5. Expression of CaGIT3, CaGIT4, and CaGDE1 is regulated by phosphate
availability. WT-DAY185 was grown in synthetic YNB liquid media supplemented with
Low Pi (200M) or High Pi (10mM) KH2PO4 to log phase. Cells were harvest, RNA was
extracted and expression of CaGIT3, CaGIT4 and CaGDE1 was measured by
quantitative real-time PCR. CaTDH3 was used as an endogenous control. Fold change in
expression was calculated between WT-DAY185 Low Pi and High Pi. Values were
normalized to 1. Values represent mean ± standard error (SE) of triplicate determinations.
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3.3.4 Loss of CaGDE1 alters GroPCho catabolism. Since deletion of CaGIT2-4 did not
completely abolish the ability of C. albicans to utilize GroPCho as a phosphate source,
we next deleted a gene predicted to be involved in GroPCho catabolism. A single ORF in
the C. albicans genome has sequence similarity to S. cerevisiae GDE1 (YPL110C),
which codes for a protein with glycerophosphodiesterase activity specific for GroPCho
(66,104). Using NCBI BLAST (103) (default settings, CGD) ORF 19.3936, here named
CaGde1, was found to have 42% identity match and 58% positive match to ScGde1 with
15% gaps. ScGDE1 is predicted to encode a cytosolic protein of 1223 amino acids, while
CaGDE1 is predicted to encode a cytosolic protein of 1162 amino acids. Homozygous
deletion of CaGDE1 (gde1/+pDDB78) did not abolish the cells ability to utilize
GroPCho as sole phosphate source, although there was a measurable difference between
wild type and the gde1/+pDDB78 strain (FIG 3-3A). The difference in growth was
rescued when a copy of CaGDE1 (pDDB78GDE1) was reintegrated into the genome of
the gde1/ strain (FIG 3-3A). The difference in growth was rescued when a copy of
CaGDE1 (pDDB78GDE1) was reintegrated into the genome of the gde1/ strain (FIG
3-3A). We next performed short-term (2 min) transport assays followed by the analysis
of the internal metabolites. As shown in Figure 3-3B, internal [3H]GroPCho as well as
[3H]choline were present in a wild-type strain. In the homozygous deletion mutant, we
observed a build up of internal [3H]GroPCho and minimal levels of [3H]choline.
Reintegration of one copy of CaGDE1 resulted in wild-type levels of [3H]GroPCho and
[3H]choline, suggesting that CaGDE1 codes for a glycerophosphodiesterase that acts on
GroPCho. As a control, git2-4/+pDDB78 was also included to show that GroPCho is
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not internalized in the absence of a transporter. Similar to CaGIT3 and CaGIT4, growth
in the presence of high phosphate reduced the expression of CaGDE1 (Table 3-5).
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Figure 3-3. Deletion of CaGDE1 results in altered GroPCho catabolism. (A) Strains
were grown in synthetic YNB liquid media lacking phosphate and supplemented with
200M GroPCho. Cultures were incubated at 30oC with shaking and A600 readings taken
incrementally over 48 hours. (B) Strains were grown to log phase in synthetic YNB Low
phosphate media, harvested and incubated with [ 3H] GroPCho for 2 minutes. Internal
pools of [3H]GroPCho and [3H]Choline were determined by ion-exchange
chromatography. Values represent mean ± standard error (SE) of triplicate
determinations. Strains are WT-DAY185 or gde1/, which was reintegrated with an
empty vector (pDDB78) or CaGDE1 (pDDB78GDE1).

67

3.3.5 CaGit3 and CaGit4 independent utilization of GroPCho. To explore the growth
observed in a git2-4/ strain that began to occur roughly 12 hours after inoculation (FIG
3-1A), we monitored the incorporation and catabolism of [3H]GroPCho by monitoring
both intracellular and extracellular water-soluble fractions at incremental time points over
24 hours. For these assays, the medium was supplemented with 200M KH2PO4 in
addition to [3H]GroPCho to supply a phosphate source for initial growth of the git2-4/
mutant. Focusing on the internal fraction of the wild-type strain (FIG 3-4A), the level of
[3H]GroPCho seen at 6 hours decreased thereafter, and a parallel increase of internal free
[3H]choline occurred. This data suggests that the internal GroPCho was being hydrolyzed
to [3H]choline and GroP . The lack of free [3H]choline at the 24 hour time point can be
explained by the fact that it had been incorporated into phosphatidylcholine and thus was
not present in the water-soluble fractions (data not shown). Outside of the cell, the level
of [3H]GroPCho decreased with time as it was transported into the cell, but reached a
plateau at approximately 12 hours (FIG 3-4B). Notably, if [3H]choline appeared in the
extracellular fraction starting at approximately 6 hours, suggesting that external
hydrolysis was occurring parallel to GroPCho transport (FIG 3-4B).
In the git2-4/ mutant we were unable to detect any significant levels of internal
[3H]GroPCho over 24 hours of growth (FIG 3-4C), indicating that deletion of CaGIT2-4
abolished the cells’ ability to transport intact GroPCho even over 24 hours.
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Figure 3-4. Internalization of intact [3H]GroPCho does not occur in the absence of
CaGIT3 and CaGIT4, though some [3H]GroPCho is hydrolyzed extracellularly.
Strains were grown in liquid YNB synthetic media containing 200M KH2PO4 in the
presence of [3H] GroPCho. At each time point, samplings were harvested and separated
into extracellular and intracellular fractions. Each fraction was analyzed by ion-exchange
chromatography to determine the distribution of counts into either [ 3H]GroPCho or
[3H]Choline. Values represent means ± standard error (SE) of duplicate determinations.
A) Intracellular and B) Extracellular fraction of WT-DAY185. C) Intracellular and D)
Extracellular fraction of git2-4/ with an empty vector (pDDB78) reintegrated. E)
Intracellular and F) Extracellular fraction of git2-4/ with CaGIT3 (pDDB78GIT3)
reintegrated.
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Importantly, after 12 hours of growth we were able to detect internal [ 3H]choline in the
git2-4/ mutant (FIG 3-4C), as well as a decrease in extracellular [3H]GroPCho (FIG 34D) and the appearance of external [3H]choline. These data suggests that [3H]GroPCho
was being hydrolyzed outside of the cell to release free choline, as was the case for wild
type (FIG 3-4B).
Since CaGit3 is the primary permease for GroPCho, we analyzed the git2-4/
mutant with CaGIT3 reintegrated into the genome to verify that intracellular and
extracellular levels of metabolites were returned to that of wild type (FIG 3-4E &F) in the
presence of a GroPCho permease. Radioactivity not accounted for in the extracellular and
intracellular fractions was detected in the membrane fraction by way of free choline
incorporation into newly synthesized phosphatidylcholine (data not shown).
To summarize the results of Figure 3-4, the data suggest that during the first
roughly 12 hours post-inoculation, wild type cells were utilizing GroPCho by
transporting it in the cell (primarily via CaGit3) and hydrolyzing it to release free choline.
After 12 hours of growth, when there was little continued uptake of intact GroPCho, the
most likely scenario was that GroPCho was being hydrolyzed extracellularly and the
resulting metabolites transported into the cell as needed. The hydrolysis of GroPCho into
free choline and GroP is the most likely pathway given that we did not detect cholinephosphate in internal or external fractions.
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Figure 3-5. CaPho4 is partially responsible for regulating CaGIT3 CaGIT4 and
CaGDE1 under low phosphate conditions. A) Wild type (WT-TF) and pho4/ strains
were grown in synthetic YNB liquid media lacking phosphate (No P i), supplemented with
200M KH2PO4 (Low Pi) or 200M GroPCho. Cultures were incubated at 30oC with
shaking and A600 readings taken incrementally over 24 hours. B) Strains were grown to
log phase in Low Pi medium. Cells were harvested, washed and analyze for their ability
to transport [3H] GroPCho over 2 min. C) Strains were grown to log phase in Low Pi
medium. Cells were harvest, RNA was extracted and expression of CaGIT3, CaGIT4 and
CaGDE1 was measured by quantitative real-time PCR. CaTDH3 was used as an
endogenous control. Fold change expression was calculated compared to WT-TF and
values were normalized to 1. Values represent mean ± standard error (SE) of triplicate
determinations. Experiments were repeated with similar results.
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3.3.6 CaPHO4 Regulates the Expression of CaGIT3, CaGIT4 and CaGDE1. CaPho4
regulates the expression of CaGIT1 and thereby regulates the transport of GroPIns by C.
albicans (97). In FIG 3-5A, a wild type strain and a pho4/ mutant were grown on
synthetic media either lacking phosphate supplemented with KH 2PO4, or supplemented
with GroPCho. Although no differences in growth were observed (FIG 3-5A), initial
[3H]GroPCho transport activity was greatly reduced in the pho4/ mutant (FIG 3-5B). It
is not surprising that the activity remaining in the pho4/ mutant (250 pmol/min/ODU)
was enough to support full growth on GroPCho (Fig 3-5A), as this level of activity is
enough to support full growth on GroPIns as a phosphate source (97). Quantitative RTPCR analysis of gene expression was performed for CaGIT3, CaGIT4, and CaGDE1 in
WT-TF and the pho4/ mutant grown under low Pi conditions (FIG 3-5C). Normalizing
the WT-TF to 1, an approximate 10-fold reduction in mRNA levels was evident for both
CaGIT3 and CaGDE1 in the pho4/ strain. CaGIT4 showed a roughly 4-fold decrease
in message levels in a pho4/ strain as compared to WT-TF.

3.3.7 Kinetics of GroPCho transport by CaGit3 and CaGit4. Given that our results
indicated that both CaGit3 and CaGit4 act as GroPCho transporters, we used a git4/
mutant to analyze CaGit3 transport kinetics and a git3/ mutant to analyze CaGit4
transport kinetics. For analyzing kinetics, strains were grown in synthetic media
containing low phosphate. Initial transport of [ 3H]GroPCho by both CaGit3 and CaGit4
conformed to Michaelis-Menton kinetics
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Figure 3-6. Kinetics of GroPCho transport by CaGit3 and CaGit4. Strains were
grown to log phase in synthetic YNB Low phosphate media, harvest, washed and assayed
for initial transport of [3H] GroPCho at varying concentrations of GroPCho substrate. A)
git4/ mutant is assayed to analyze transport activity of CaGit3 from 20M to 1mM
GroPCho. B) git3/ mutant is assayed to analyze transport activity of CaGit4 from 5M
to 200M GroPCho. [3H] GroPCho transport activity is plotted against initial
concentrations of GroPCho. Data were linearized using Hanes plot transformations (Inset
A & B).
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(FIG 3-6A&B). Under the given conditions, CaGit3 exhibited a Vmax of 3940±150
pmol/min/ODU and a Km of 45±6 M. CaGit4 exhibited a Vmax of 340±40
pmol/min/ODU and a Km of 16±7 M. Data was transformed into a Hanes plot (Inset
FIG 3-6A&B) to verify linearity and the presence of a single transporter for each
analysis. The error bars observed for the minor transporter, CaGit4, are attributed to the
fact that transport was quite low compared to CaGit3 and that it was greatly affected by
small changes in the cell density at inoculation as well as cell density at the time of
harvesting cells for the assay.

3.3.8 GroPCho utilization under serum growth conditions. In an attempt to explore
the relevance of the GroPCho transport under conditions similar to those experienced in a
human host, we performed GroPCho incorporation experiments in the presence of 10%
serum and 1 mM KH2PO4, which is within the phosphate concentration range reported
for serum (105). Cultures were allowed to grow for 6 hours at 37°C at which point the
internal metabolites were analyzed (FIG 3-7). Both [3H]GroPCho and [3H]choline were
detected internally in a wild-type strain. When CaGIT2-4 were deleted, no internal
radiolabeled metabolites were detected. Upon reintegration of CaGIT3, wild-type levels
of metabolites were observed. A minimal amount of [3H]GroPCho was detected when
CaGIT4 was reintegrated. A strain containing a homozygous deletion of CaGDE1
exhibited a build up of [3H]GroPCho and less [3H]choline compared to wild-type levels.
Upon reintegration of CaGDE1, internal metabolites returned to levels similar to wild
type.

75

Figure 3-7. GroPCho is transported and metabolized in the presence of serum.
Strains were pre-grown in synthetic YNB media containing 1 mM KH2PO4 (YNB 1mM
Pi). The assay was initiated by inoculating cultures of synthetic YNB 1mM Pi medium
containing 10% Bovine Serum and 200 M [3H]GroPCho to A600 0.1. Cultures were
incubated at 37oC for 6 hours with agitation. After 6 hours, cultures were separated into
extracellular, intracellular and membrane fractions. Factions were analyzed by liquid
scintillation counting. [3H]Choline metabolite ratios were determined by ion exchange
chromatography. Cell growth between the hyphae forming strains, was normalized using
XTT reduction analysis (Abnova) performed parallel to the radioactive assay. Results
shown represent mean ± SE of duplications. Experiment was repeated with similar
results. Strains are WT-DAY185, git2-4/, which was reintegrated with an empty
vector (pDDB78), CaGIT3 (pDDB78GIT3), or CaGIT4 (pDDB78GIT) and gde1/,
which was reintegrated with an empty vector (pDDB78) or CaGDE1 (pDDB78GDE1).
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These results indicate that both CaGit3 and CaGde1 are active in the presence of serum,
which is known to contain GroPCho (61,98,106). Cell growth was monitor by XTT
reduction assay in order to analyze growth across strains that are hyphae forming and
clumping in the presence of serum.

3.4 Discussion
Glycerophosphodiesters are produced through the activity of deacylating
phospholipases, such as those of the A1, A2 and B-type. B-type phospholipases (PLBs),
enzymes that can remove both fatty acyl esters, are found in many organisms including
bacteria (107,108), humans (109), and fungi (29). PLBs are considered virulence factors
for several pathogenic fungi (26,110). Not surprisingly, glycerophosphodiesters are
common metabolites, having been found in many cell types and, importantly, are
reported to occur in several locations in the human body, including serum (56-59,6163,98). Our work and that of others has shown that extracellular and intracellular
glycerophosphodiesters are recycled into biological molecules through some combination
of transport and hydrolysis (44,49,50,66,97,104). C. albicans' ability to transport
glycerophosphodiesters is expanded as compared to the non-pathogenic S. cerevisiae
(97). While S. cerevisiae has one transporter (ScGit1) responsible for GroPIns and
GroPCho transport, C. albicans has four ORFs with similarity to ScGIT1 and much
greater GroPCho transport activity (97). Additionally, we reported that while CaGit1 is
responsible for GroPIns transport, GroPCho is utilized by a different mechanism (97).
The data presented here indicate that there are two transporters specific for GroPCho
uptake in C. albicans, CaGit3 and CaGit4. Evidence to support this conclusion is two-
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fold: i) either CaGit3 or CaGit4 is required for early post-inoculation growth when
GroPCho is supplied as sole phosphate source (FIG 3-1A) and ii) measurable initial
transport of GroPCho requires either CaGit3 or CaGit4, with CaGit3 displaying much
greater initial transport activity (FIG 3-2A&B). Nonetheless, cells lacking CaGIT3 and
CaGIT4 are able to initiate growth on GroPCho 12-18 hours post inoculation (FIG 3-1A),
suggesting that an alternate mechanism for GroPCho utilization is initiated in that time
frame. Our data, obtained using [3H]GroPCho in which the choline molecule was labeled,
indicate that this alternate mechanism involves the extracellular hydrolysis of
[3H]GroPCho to [3H]choline and GroP, as we observe the production of extracellular
[3H]choline (FIG 3-4D). Presumably the unlabeled GroP is hydrolyzed to release free
phosphate that is utilized by the cell. The hydrolysis of [ 3H]GroPCho into [3H]choline
and GroP is the most likely pathway given that we did not detect [ 3H]choline-phosphate
in internal or external fractions. It is worth noting that this transporter-independent
pathway for GroPCho utilization does not exist in S. cerevisiae, where deletion of
ScGIT1 completely abolishes the ability of cells to utilize GroPCho as a phosphate source
(66).
Glycerophosphodiesters are hydrolyzed to GroP and their respective alcohol by
glycerophosphodiesterases (30,46). In order to better understand GroPCho catabolism in
C. albicans, we deleted CaGDE1 (ORF 19.3936), which is predicted to be a cytosolic
protein with a glycerophosphodiester phosphodiesterase domain. CaGde1 is highly
similar to the only known GroPCho glycerophosphodiesterase in S. cerevisiae (ScGde1)
and is annotated CGD as a glycerophosphodiester glycerophosphodiesterase using
InterPro (IPR004129) (35). Loss of CaGDE1 results in a build up of internal GroPCho
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(FIG 3-3B), providing evidence that CaGde1 acts upon GroPCho. However, loss of
CaGDE1 does not abolish GroPCho utilization (FIG 3-3A), so other gene products must
exist that are capable of hydrolyzing GroPCho, but that are less similar to a standard
glycerophosphodiesterase (IPR004129). This result also stands in contrast to that which
occurs in S. cerevisiae, where deletion of ScGDE1 renders the cells unable to grow on
GroPCho as a phosphate source (66).
Glycerophosphodiesterase activity is present in a wide range of organisms,
including mammals, plants, and bacteria (30). In mammalian cells, several putative
glycerophosphodiesterase domains have been identified (46). For example, GDE5
selectively hydrolyzes GroPCho and has been implicated in skeletal muscle development
(47). In E. coli, a multi protein complex, the Ugp system (consisting of UgpB,A,E,C, and
Q), exists to utilize GroPCho and is regulated by phosphate availability (43-45). UgpB
binds GroPCho and brings it to 3 membrane proteins, UgpA, UgpE and UgpC, which are
required for GroPCho transport. As GroPCho is transported, it is hydrolyzed by a
cytosolic glyerophosphodiester phosphodiesterase, UgpQ (44). In two separate plant
models, glycerophosphodiesterase activity has been linked to phosphate starvation
(49,50). In Arabidopsis thaliana, phosphate starvation induces the expression of
glycerophosphodiesterases and plants lacking the corresponding genes exhibit decreased
growth rates (49). In White Lupin (Lupinus albus), two glycerophosphodiesterases (GPXPDE1 and GPX-PDE2) have been characterized (50). Upon phosphate starvation,
expression of GPX-PDE1 and GPX-PDE2 is up-regulated and both enzymes are linked to
the growth of root clusters (50). Interestingly, GPX-PDE1 complements the S. cerevisiae
gde1 mutant (50), in terms of growth on GroPCho as a phosphate source (66).
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As has been reported for plants and bacteria, we show here that GroPCho
utilization in C. albicans is linked to phosphate limitation. CaPHO4 and CaGRF10 are
orthologs to ScPHO4 and ScPHO2 (68), genes that encode transcription factors that
regulate phosphate responsive genes in S. cerevisiae (86,87). As was the case for CaGit1
(97), the transcriptional regulator CaPho4 regulates the expression of CaGIT3 ,GIT4, and
CaGDE1 (FIG 3-5C). However, loss of CaGRF10 does not affect the ability of C.
albicans to utilize GroPCho (data not shown). Additionally, CaGRF10 does not a
regulate the expression of CaGIT1 (97) and others have noted that it does not appear to
be involved in the phosphate response in C. albicans (99). Interestingly, a recent report
indicates that phosphate limitation might have implications for C. albicans virulence
(99). In this study, C. albicans strains isolated from the stool of critically ill patients
underwent filamentation and expressed a lethal phenotype against mice and C. elegans
upon phosphate limitation (99). It is tempting to speculate that the phosphate-regulated
genes involved in GroPIns (CaGit1) (97) and GroPCho (CaGit3, CaGit4, and CaGde1)
utilization may play a role in these phenotypes.
Besides acting as a nutrient source, other functions have been ascribed to
GroPCho. A well-known function involves osmotic regulation in renal medullary tissue
of mammals, where GroPCho counteracts the effects of high NaCl and urea
concentrations (48,56). In the fungal pathogen, Cryptococcus neoformans, GroPCho
appears to be required for capsule enlargement (110). Capsule enlargement is necessary
for this organism's virulence, as it provides protection from phagocytosis as well as
oxidation (110). A C. neoformans strain lacking phospholipase B1 (PLB1) loses its
ability to enlarge its capsule, but supplementation of GroPCho rescues this phenotype
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(110). Interestingly, C. neoformans contains a putative protein that is 42% similar
(NCBI-Blast) to CaGit3 suggesting that it too may transport intact GroPCho.
Although a GroPIns permease (GLUT2) has been identified in mammalian cells
(41) and GroPCho transport has been described in E. coli (43,45), to the best of our
knowledge, this is the first identification of a GroPCho permease in a eukaryotic
organism. Interestingly, proteins with high similarity to the major GroPCho permease,
CaGit3, appear to be widespread in fungi. A NCBI blast (103) search of protein
sequences from fungal organisms revealed 11 organisms that contain one or more
predicted proteins with at least 50 % identity match to CaGit3. Within the Candida
species, C. dubliniensis, C. parapsilosis, C. tropicalis and C. orthopsilosis all contain one
or more predicted proteins that range between 73-98% identical to CaGit3.
We have shown previously that C. albicans is able to utilize GroPCho under
conditions of elevated temperature and pH found in the human body (97). Here we show
that C. albicans employs CaGit3 to transport and CaGde1 to metabolize GroPCho in the
presence of serum and the concentration of phosphate found in serum, roughly 1 mM
(FIG 3-7). Serum contains not only GroPCho, but also its precursor, phosphatidylcholine
(61,98). Thus, our results offer evidence that glycerophosphodiester transport and
metabolism are physiological relevant cellular functions under conditions of human
infection. Obvious future experiments to pursue include those aimed at determining the
role, if any, that these gene products play in pathogenicity or the ability of the organism
to colonize the human host.
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Chapter 4
Conclusions
My work has resulted in several clear contributions to our understanding of
glycerophosphodiester transport and metabolism in C. albicans. I have identified CaGit1
as the permease responsible for the transport of GroPIns into the cell. I have identified
CaGit3 and CaGit4 as two novel permeases responsible for the transport of GroPCho into
the cell. This is the first report of an eukaryotic transporter with high specificity for
GroPCho. I have shown that CaGde1 is a glycerophosphodiesterase involved in internal
GroPCho metabolism. Also my work has demonstrated that CaGIT1, CaGIT3, CaGIT4,
and CaGDE1 expression is regulated by the CaPho4 transcription factor. Finally, I have
shown that glycerophosphodiester transport and metabolism occurs under conditions that
may be experienced in a human host.

4.1 Comparison of glycerophosphodiester metabolism in C. albicans and
S. cerevisiae.
Many noteworthy similarities and differences between S. cerevisiae and
C. albicans have been demonstrated in this study. Based on the results presented in the
study, CaGit1 is the ortholog of ScGit1. Their protein sequences are also similar (FIG 41A). Both of these proteins transport intact GroPIns into the cell with similar estimated
Km and Vmax values under the conditions studied. In contrast to ScGit1, CaGit1 does not
transport GroPCho. Another difference between the two proteins is that CaGit1 functions
at physiological pH, but ScGit1 does not.
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The addition of ORFS CaGIT2-4 as a tandem repeat on chromosome 5 has
increased ability of C. albicans to utilize GroPCho. I have determined that CaGit3 is a
GroPCho permease that is responsible for the majority of GroPCho transport. Although
CaGit4 does have minimal level of transport activity, the Km and Vmax for CaGit3 are
much higher. Interestingly, the Km and Vmax of CaGit3 are very similar the Km and Vmax
reported for the inorganic phosphate transporter in S. cerevisiae, ScPho84 (111). Thus,
not only can C. albicans utilize glycerophosphodiesters more robustly than S. cerevisiae,
it can transport GroPCho at a rate similar to that by which S. cerevisiae transports
phosphate (under the given conditions). Both CaGit3 and CaGit4 are also active at
alkaline pH (FIG 2-4, Appendix A-3).
Another difference between the two organisms is that C. albicans can utilize
glycerophosphodiesters in the absence of the permease that transports the metabolite into
the cell, while S. cerevisiae cannot. S. cerevisiae strains lacking the only
glycerophosphodiester permease, ScGit1, are unable to utilize GroPIns or GroPCho for
growth a phosphate source (66,67). In contrast, C. albicans can utilize GroPIns and
GroPCho in the absence of an appropriate permease. In the absence of CaGit1, C.
albicans is able to utilize GroPIns as a phosphate source for growth when the pH of the
growth media is elevated (7.5). Similarly, in the absence of CaGit3 and CaGit4, GroPCho
can be utilized as a phosphate source 12-18 hours post inoculation at all pHs tested. In
both cases, the data indicates that glycerophosphodiesters are being hydrolyzed
extracellularly to release components that can be taken up by other transporters. Thus, C.
albicans has also increased its ability to catalize glycerophosphodiesters compared to S.
cerevisiae. In S. cerevisiae, deletion of ScGde1 eliminates the cells ability to utilize
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GroPCho (66,104). Since elimination of CaGde1 reduces, but does not abolish the cell’s
ability to utilize GroPCho, there must be one or more enzymes having specificity for
GroPCho. Additionally, I have evidence that CaGde1 has activity for internalized
GroPIns (Appendix A.8). In contrast, the ScGde1 does not hydrolyze GroPIns and a
glycerophosphodiesterase specific for GroPIns in S. cerevisiae is unknown (30). In the
current ORF assembly, C. albicans does not contain any proteins with sequence
similarities to ScPho5, the major phosphatase in S. cerevisiae (44,112). Interestingly, C.
albicans does contain at least 10 putative phosphatase proteins, most of which are
uncharacterized and may have the ability to hydrolyze glycerophosphodiesters.

4.2 Phosphate Response in C. albicans and S. cerevisiae
The proteins investigated in this study are a part of a larger story, which is the
phosphate response in C. albicans. This response is understudied, but the initial work
here and by the others (99), has shown some interesting results. More work needs to be
performed to fully understand the importance of the phosphate response in C. albicans
and relate it to the overall pathogenicity of the organism.

4.2.1 S. cerevisiae response
The phosphate (Pi) response in S. cerevisiae has been extensively studied, and
was reviewed in Ljungdahl and Daignan-Fornier 2012. This process involves a complex
network of sensing, transporting, and signaling in response to intracellular and
extracellular Pi levels. Studies have been carried out in a number of different Pi conditions
including transitions from high Pi to low Pi, cells adapted to low Pi, and low Pi vs. Pi
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starvation (113). The phosphate response is regulated by PHO-regulatory pathway, which
includes positive regulators ScPho2, ScPho4, and ScPho81 and negative regulators
ScPho80 and ScPho85 (113). Within the phosphate response cascade, ScPho2 and
ScPho4 are transcription factors whose interaction is required for a phosphate response
under low phosphate conditions (114). ScPho80 and ScPho85, which are active when
phosphate conditions are high (115), form a protein kinase complex that interacts with
ScPho4 (116). This interaction results in the phosphorylation of ScPho4, its export from
the nucleus (117), and prevents it from activating phosphate response genes when Pi is
plentiful (115). ScPho81 has been shown to be a positive regulator of phosphate response
genes through its ability to negatively regulate ScPho80-ScPho85 complex (118),
allowing ScPho4 to remain in the nucleus. ScPho4 and ScPho2 have also been shown to
be important in the utilization of alternate phosphate sources (89). Both ScPho4 and
ScPho2 regulate ScGit1 transcription, essentially regulating transport of GroPIns and
GroPCho (89,119).
Phosphate uptake and sensing plays a major role in the regulation of phosphate
response genes (113). S. cerevisiae has two high affinity Pi transports Pho84 and Pho89
(120,121) and three low affinity P i transports Pho87, Pho90, and Pho91 (111). Pho84 and
Pho89 are both under control of the PHO-regulatory pathway and contribute to internal
levels of Pi (120,121). The high affinity transporters are not essential proteins because
low affinity transporters, function independently of internal phosphate concentrations
(122). Evidence also suggests that the low affinity transporters may be involved in
extracellular phosphate sensing contributing to the internal signaling (113).
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The PHO-regulatory network and Pi levels influence at least 6 proteins (ScPho3,
ScPho5, ScPho8 and ScPho10-12) with phosphatase activity in S. cerevisiae
(112,123,124). CaPho4 and CaPho2 have been shown to bind to the promoter region of
CaPho5 (125), the major secreted acid phosphatase in S. cerevisiae (112,124). CaPho5
expression is impacted by internal concentrations of P i, which can be greatly influenced
by phosphate transport (111,112). None of these known phosphatases in S. cerevisiae are
able to act on extracellular glycerophosphodiesters.

4.2.2 C. albicans response
Very few studies have reported on phosphate responsive genes in C. albicans.
Most of the ORFs are uncharacterized and named based on sequence similarity to S.
cerevisiae ORFs. In all but a few cases, the ORFs have merely been incorporated into
more global studies looking at transcriptional profiling of biofilms (126-128),
morphology changes (129-131), and other various stressors including changes in osmotic
pressure, oxidation state, pH, and the presence of antifungal drugs (132-135).
Interestingly, one expression study analyzing message levels from C. albicans strains
isolated from a mouse virulence model shows upregulation of CaPHO84, CaPHO87, and
CaPHO100 (homolog of ScPHO3) which are predicted to code for a high affinity
phosphate transporter, a low affinity phosphate transporter, and an acid phosphatase,
respectfully (91). A NCBI BLAST search reveals that CaPho84 is 66 % identity match
with 4% gaps to ScPho84, the primary high affinity phosphate permease in S. cerevisiae
(120). Additionally, CaPHO84 and CaGIT3 expression has also been shown to be
upregulated in biofilms (126).
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The only C. albicans PHO-related ORFs to be characterized is CaPHO4, which
encodes the transcription factor CaPho4. Aside from work in this dissertation, one study
to date has reported specifically on the phosphate response in C. albicans involving
CaPho4 (99).This study showed that CaPHO4 expression was upregulated under
phosphate limiting conditions (99). This report complements my findings that show
CaPho4 regulates the expression of CaGIT1,CaGIT3, CaGIT4, and CaGDE1. In contrast
to S. cerevisiae, interactions between transcription factors ScPho4 and ScPho2 are not
required for the activation of phosphate responsive genes. Our data and others (99) were
unable to find a connection between CaPho2 and a response to PHO-regulatory pathway.
This is not entirely surprising, as others have reported on the differences between the
regulatory circuits between S. cerevisiae and C. albicans (78,136).

4.3 Putative glycerophosphodiester permeases across fungal species
To gain a perspective on the potential proteins with glycerophosphodiester
transport activity in other fungal species besides C. albicans and S. cerevisiae, a NCBI
BLAST search was performed using ORF translations of both CaGit1 and CaGit3
obtained from CGD. The purpose was to determine if there are homologous GIT-related
proteins in other fungal pathogens. Data from this search are compiled in Table 4-1 and
Appendix A-1. This search resulted primarily in human and plant pathogens from the
Ascomycota phylum with the exception of two species, Cryptococcus neoformans and
Cryptococcus gattii, from the Basidiomycota phylum. For comparison purposes CaPol3,
a protein coding for DNA polymerase 3 in C. albicans, was also included in this search to
show similarities of an essential protein among these species. Species that contained GIT-
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related proteins that are very similar (> 70% identity match) to C. albicans GIT-related
proteins, also contained Pol3 proteins that are very similar (> 70% identity match) to
CaPol3. Most of these proteins were in the Candida genus, with the exception of
Lodderomyces elongisporus, a relative of the Candida Genus. L. elongisporus, by
comparative sequence analysis, is roughly 97.5 % similar to C. albicans (137). In the
more divergent genera, Apergillus and Coccidioides, the protein with the highest
similarity to GIT-related proteins are between 50-60% identity match to CaGit1 and
CaGit3, but their respective Pol3 proteins are also less similar (~60% identity match). It
is tempting to speculate that these putative GIT-related proteins may experience similar
evolutionary pressure as an essential protein, such as DNA polymerase 3, due to the
environments in which they colonize.
The presence of one or more proteins with similarity to CaGit1 or CaGit3
occurred in species other than C. albicans (C. dubliniensis, C. orthopsilosis, C.
parapsilosis, C. tenuis, and C. tropicalis) (Table 4-1). Many contained proteins ranging
between 74 and 98 % identity match to CaGit1 and CaGit3, coving over 90% of the
protein. It is worth mentioning that Candida species that are not known to impact human
health were not prevalent in this search, though roughly 190 exist. This observation is
most likely due to the lack of sequence data for these species that pose little risk to
humans. This may be result from a greater emphasis on sequencing the genomes of
species that are human pathogens.
Other fungal species diverged from the Candida genus contain GIT-related
proteins (Appendix A-1). Aspergillus fumigatus, like C. albicans, is considered to be a
common cause of fungal infection in humans (138). A. fumigatus, found commonly in
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Table 4-1 Putative glycerophosphodiester permeases of common fungal species
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Table 4-1 Putative glycerophosphodiester permeases of common fungal species.
NCBI BLAST search of three C. albicans proteins, CaGit1, CaGit3, and CaPol3 against
pathogenic and non-pathogenic fungal species. Column 1 indicates the genus (bold)
followed by one or more species. Columns 2 and 3 indicate the fungal strains that were
sequenced to obtain the putative protein sequence and the NCBI reference sequence
number for each protein. Columns 4-6 indicate the percent identity match for each
putative protein against CaGit1, CaGit3, and CaPol3. Proteins with greater than 50%
Identity match to CaGit1 are bolded in column 4 and the species is highlighted blue in
column 1. Proteins with greater than 50% Identity match to CaGit3 are bolded in column
5 and the species highlighted orange in column 1. The percent coverage for each protein
was 90% or greater.
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soil, exist as a spore that can potentially enter humans through inhalation (138). Similar
to C. albicans, A. fumigatus primarily causes issues for individuals with compromised
immune systems (138). The Aspergillus genus contains many different species (Appendix
A-1), but only a few have been associated with human infection (138).
Interestingly, many of the species, A. fumigatus, A. terreus, A. nidulan, A.
clavatus, A. flavus, and A. oryzae contain putative proteins that are greater than 50%
identity match to CaGit3 and the species A. niger and A. kawachii contain putative
proteins that are greater than 50% identity match to CaGit1. Another fungal pathogen,
Coccidioides immitis, normally found in soil, but also has the potential to infect humans
(139), has one putative protein that is greater than 50% identity to CaGit3.
The common fungal species, Cryotococcus neoformans, contains 2 GIT-related
proteins, although they are less similar to CaGit1 and CaGit3 (<50% identity match)
(Appendix A-1). This is not surprising given that this species belongs to different
phylum, Basidiomycota (140), but still interesting because a recent report tied GroPCho
to the virulence of C. neoformans (110).
Of all the species indentified in this search, only one was not a human pathogen.
This species, Magnaporthe oryzae, is a plant pathogen affecting rice (141). M. oryzae has
three putative GIT-related proteins, all of which are less than 50% identity match to
CaGit1 and CaGit3 (Appendix A-1). Evidence of GIT-related proteins in these species
that have diverged from C. albicans provides evidence that these types of proteins have
survived and in many cases expanded within particular species.
Pathogenic organisms have increased their frequency of genes involved in
pathogenicity and nutrient acquisition as compared to non-pathogenic organisms
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(17,139,142,143). In particular, cell wall associated proteins and secreted hydrolytic
enzymes have been investigated (139,144). Not surprisingly these gene duplications are
associated with the proteins products of recognized virulence factors. Still, gene
duplications relevant to nutrient transport have been reported (142,143). C. albicans
contains a family of six polyamine transporters, compared to one is S. cerevisiae, which
play a role in transporting polycationic molecules necessary for protein and nucleic acid
synthesis (143). Additionally, a family of nine oligopeptide transporters exists in the C.
albicans genome compared to three in S. cerevisiae, with CaOPT7 being involved
glutathion utilization (142). The duplication of putative glycerophosphodiester transport
proteins in C. albicans compared to S. cerevisiae may be another instance of C. albicans
increasing its ability to utilize potential nutrient sources.

4.4 Open Questions
The summary of glycerophosphodiester metabolism in C. albicans (FIG 4-1) is
based primarily on the work described in my dissertation. However, several open
questions still remain. First is the characterization of the CaGit1-CaGit3-CaGit4
independent utilization of GroPIns and GroPCho. This could be addressed through i) the
identification of enzymes that are hydrolyzing extracellular GroPIns and GroPCho, ii)
determining to what extent these enzymes are regulated by phosphate and iii) analyzing
the role, if any, CaGit3 or CaGde1 play the activation of this novel scavenging pathway.
This alternate pathway may in fact be a major contributor to ability of C. albicans to
invade host tissue, especially under low phosphate environments. An experiment to
identify potential proteins involved in extracellular hydrolysis of GroPIns and GroPCho
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Figure 4-1 Summary of glycerophosphodiester transport and metabolism in
C. albicans. This schematic offers a summary of what is currently known for
glycerophosphodiester transport and metabolism in C. albicans. Extracellular GroPIns
and GroPCho can be obtained from the environment. Presumably, PLB-mediated
hydrolysis of phospholipids could also results in extracellular GroPIns and GroPCho, as
it does in S. cerevisiae, but this has not been documented for C. albicans. GroPIns is
transported through the permease Git1, while GroPCho is transported primarily by the
permease Git3 and minimally by the permease Git4. Once internalized, GroPCho and
GroPIns are hydrolyzed by the glycerophosphodiesterase, Gde1, producing GroP and
either free choline or inositol. Both choline and inositol can then be reincorporated into
newly synthesized phospholipids.
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would be to analyze mRNA levels of putative phosphatases on CGD. Since I have shown
that extracellular hydrolysis of GroPCho occurs 12-18 hours post inoculation (Fig 3-4),
mRNA could by analyzed incrementally over 24 hours of growth. Furthermore, if
CaGIT2-4 are not present and the strains are forced to utilize GroPCho as a phosphate
source, potential candidates may show increase levels of mRNA expression compared to
strains grown on a different phosphate source (KH2PO4). Additionally, analyzing mRNA
expression of putative phosphatases in strains lacking CaGIT3 or CaGDE1 would
provide information on the role, if any, these ORFs play in the regulation of this alternate
pathway from GroPCho utilization.
Another question that would be interesting to pursue is the role of CaGit2, which
is currently unknown. From work performed here, CaGit2 is unable to transport GroPIns
or GroPCho, but this does not rule out specificity for other glycerophosphodiesters
(GroPS or GroPE). Interestingly, the precursors of these glycerophosphodiesters,
phosphatidylserine and phosphatidylethanolamine, are also present in the human host
(145). An experiment to determine if CaGit2 has specificity for GroPS or GroPE would
be to utilize a git2-4/ strain with either an empty vector (pDDB78) or CaGIT2
(pDDB78GIT2) reintegrated into the genome. Along with a wild type strain
(WTDAY185), these two strains can be tested for their ability to utilize GroPS and
GroPE as phosphate sources.
Based on work in this dissertation, the permease CaGit4 is able to transport low
levels of GroPCho. This activity appears to be insignificant to CaGit3 transport activity,
but may have a secondary role. It is interesting to speculate that CaGit4 and CaGit2 may
also play a role in sensing alternate phosphate sources. S. cerevisiae has a developed
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systems for sensing glucose (146) and its believed that its low affinity Pi transporters may
also play a role in sensing phosphate availability (113). Given that C. albicans has
increased its ability to transport alternate phosphate sources, it is not out of the questions
to think that this pathogen may have developed strategies for sensing extracellular
phosphate sources.
Lastly, the involvement the glycerophosphodiester utilization by the CaGit1/3/4
dependent and independent pathways has in the pathogenicity and commensal growth in
a mammalian host should be pursued. Results from my dissertation show that these
mechanisms are active under conditions that C. albicans may experience in a human host,
suggesting that they may play a role in nutrient acquisition during infection.
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Appendix
The appendix contains preliminary experiments of interest that were not pursued further
and were not included in the publications that make up chapter 2 and 3. Some of the data
included in this appendix is relevant for discussion purposes for Chapter 4.

A.1

112

A.1 Putative glycerophosphodiester permeases of non-Candida fungal species. NCBI
BLAST search of three C. albicans proteins, CaGit1, CaGit3, and CaPol3 against
pathogenic fungal species. Column 1 indicates the genus (bold) followed by one or more
species. Columns 2 and 3 indicate the fungal strains that were sequenced to obtain the
putative protein sequence and the NCBI reference sequence number for each protein.
Columns 4-6 indicate the percent identity match for each putative protein against CaGit1,
CaGit3, and CaPol3. Proteins with greater than 50% Identity match to CaGit1 are bolded
in column 4 and the species is highlighted blue in column 1. Proteins with greater than
50% Identity match to CaGit3 are bolded in column 5 and the species highlighted orange
in column 1. All of the genera listed in this figure are members of the Ascomycota
phylum with the exception of Cryptococcus, which is a member of the Basidiomycota
Phylum.
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A.2

A.2. Phosphate starvation of C.albicans induces invasive growth. Over night culture
of C. albicans WT (DAY185) was grown over in synthetic YNB (2% glucose) media
containing 80 g/ml uridine and 200 M KH2PO4. In H2O, cultures were diluted to OD600
of 0.4 and then diluted 1000 fold. 50 L of diluted culture was spread onto synthetic
YNB (2% glucose) agar plates with ranging initial KH2PO4 concentrations. After 7 days
of incubation at 30 °C, cell colonies were washed off with DI H 2O and the resulting cells
that had invaded the agar were visualized under 30x magnification. Colonies grown on
0.4 mM KH2PO4 (A) experience increased invasion into the agar plates compared to
1mM (B) or 5mM (C) KH2PO4. Enlarged picture of a colony on 0.4 mM KH2PO4 shows
a colony pre-washed (D) and post-washed (E).
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A.3

A.3. GroPCho competition assay and pH dependence assay. Transport assays were
perform on a C. albicans WT (DAY185) strain as described in Material and Methods:
(2.2.6) (A) [3H]GroPCho uptake in the presence of 40 mM GroP (G3P), 40 mM Choline,
40 mM sodium phosphate (Na-P) and 50 M Carbonyl cyanide 3-chlorophenylhydrazone
(CCCP). (B) [3Htransport ]GroPCho uptake in the presence of altering pH (5-8.5). GroP
competes with [3H]GroPCho uptake while choline and sodium phosphate do not (A).
The protonophore CCCP eliminates the proton gradient, eliminating [ 3H]GroPCho uptake
(A). [3H]GroPCho uptake is pH dependent (B) although a large amount of activity
remains at pH 8.5.

115

A.4

A.4 Uptake of [3H]GroPCho by C. albicans clinical isolates, ICU1, ICU12, and
SC5314. Transport assays were perform on a C. albicans WT (DAY185) strain and 3
clinical C. albicans isolates as described in Materials and Methods: (3.2.5) Isolates ICU1
and ICU12 were generously provided by Alverdy Lab at the University of Chicago,
Chicago IL (99) and SC5314 was generously provided by the Mitchell Lab at Carnegie
Mellon University, Pittsburgh PA (147). All three clinical isolates ICU1, ICU 12 (A) and
SC5314 (B) were able to transport [3H]GroPCho.
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A.5

A.5 Altered growth of C. albicans mutant zcf30Δ/Δ on GroPCho as sole phosphate
source. C. albicans strains WT-TF and zcf30/ were grown as described in Materials
and Methods: (3.2.1). Transport assays were performed as described in Materials and
Methods: (3.2.5). A strain lacking CaZCF30 (ORF19.5251) exhibited a decrease in
growth on GroPCho as the sole phosphate source in the first 12 hours post inoculation
(A). Both [3H] GroPCho transport activity (B) and internal [ 3H]choline metabolites (data
not shown) were unaffected in strains lacking CaZCF30.
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A.6

118

A.6 GroPCho and GroPIns are able to support C. albicans biofilm growth.
C. albicans strains were grown overnight in synthetic YNB (2% glucose) medium
containing 80 g/ml uridine and 200 M KH2PO4. Four ml of bovine serum (Sigma
B9433) was added to 6 well culture plates (Cellstar Cat. No. 657 185) and incubated for
24 hours. The bovine serum was replaced with 4 ml of synthetic YNB (2% glucose)
media contain either 200 M KH2PO4 (Pi), 200 M GroPCho or 200 M GroPIns.
Overnight cultures were used to inoculate each well with the labeled strains to A600 of 0.5
and incubated at 37°C with agitation (35 rpm) for 90 min to allow for adherence. After
incubation, the cultures were removed from each well and 4 ml DI H2O was carefully
used to wash of cells that were not adhered to the plastic surface. Fresh media (4 ml) was
added to each well and the plates were incubated at 37°C with agitation (35 rpm) for 24
hours. GroPCho and GroPIns were able to support biofilm growth. No differences were
observed between WT(DAY185) and the various mutant strains. This suggests that the
CaGit3-CaGit4 independent pathway of GroPCho utilization is sufficient to support
biofilm growth. Strains are C. albicans WT(DAY185), git2-4/ with an empty vector
reintegrated (pDDB78) or CaGIT3 reintegrated (pDDB78GIT3) and gde1/ with an
empty vector reintegrated (pDDB78).
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A.7

A.7 Initial [3H]GroPCho uptake by 24 hour C. albicans biofilms. Biofilms were
grown for 24 hours as described in A-6 C. albicans WT (DAY286) in YNB (2% glucose)
medium containing 80 g/ml uridine and 200M KH2PO4. Biofilms were disrupted and
removed to 15 ml centrifuge tubes. Cultures were pelleted, washed and resuspended in
500 l of 25 mM Hepes buffer (pH 5) or 25 mM HEPES buffer (pH 5) with 50 M
Carbonyl cyanide 3-chlorophenylhydrazone (CCCP) by vortexing. Samples were
incubated at 37°C for 10 min with agitation and 200 l of each sample were aliquoted.
Transport assays were started by the addition of 50 l of 1 mM [3H]GroPCho and
stopped after 2 min with 10 ml of cold DI H2O. Samples were filtered through glass
filters (GF/C) and radioactivity was determined by liquid scintillation counting. Cells
from a 24 hour biofilm are able to actively transport [3H]GroPCho while transport in the
presence of protonophore CCCP eliminated transport activity.
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A.8.1

121

A.8.2 Growth Day 2

122

A.8.3 Growth Day 4

123

A.8 Phosphatidylcholine supports growth of C. albicans as a phosphate source and
growth is partially dependent on CaGIT2-4. A.8.1 C. albicans strains (1)
WT(DAY185), (2) git2-4/+pDDB78, (3) git2-4/+pDDB78GIT3, and (4)
gde1/+pDDB78 were grown overnight in YNB (2% glucose) media containing 80
g/ml uridine and 200 M KH2PO4. Cultures were then diluted to A600 0.1, 0.01, 0.001,
and 0.0001 and 5 l spotted onto YNB (2% glucose) agar plates with no phosphate (D)
containing 200 M phosphatidylcholine (A), 200 M GroPCho (B) or 200 M KH2PO4
(C). As indicated in A.8.1, plates were incubated at 30°C for 2 Days (A.8.2) and 4 Days
(A.8.3). An observed decrease in growth is observed (indicated by the arrows) for git24/+pDDB78 when GroPCho is the sole phosphate source at day 2 (A.8.2) and when
phosphatidylcholine is the sole phosphate source day 4 (A.8.3).
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A.9

A.9 Loss of CaGDE1 alters GroPIns catabolism for C. albicans. Internal [3H]inositol
metabolite were prepared as described Material and Methods: (2.2.8). Assays were
incubated with 5 M [3H]GroPIns for 5 min. In a WT(DAY185) strain, [3H]GroPIns and
[3H]Inositol are detected internally. In strains lacking CaGDE1 a build up of [3H]GroPIns
and a decrease of [3H]Inositol is observed. When one copy of CaGDE1 is reintegrated
back into the gde1/ genome, [3H]GroPIns and [3H]Inositol levels are rescued to wild
type. Strain git2-4/+pDDB78 has similar levels as WT (DAY185), as [ 3H]GroPIns
enters through CaGit1.
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